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Abbreviations 
AL ad libitum 
µg microgram 
AgRP agouti-related peptide 
Amy amygdala 
ANOVA analysis of variance 
ARC arcuate nucleus 
AUC area under curve 
avg average 
BG blood glucose 
BP break point 
bp basepair 
CCK cholycytokinin 
DA dopamine 
DAPI 4’,6-diamidino-2-phenylindole 
DIO diet-induced obesity 
dL deciliter 
DNA deoxyribonucleic acid 
DOR delta opioid receptor 
DYN dynorphin 
EDTA ethylene diamine tetra-acetic acid 
EtOH ethanol 
FR fixed ratio 
Fwd forward 
G acceleration (unit of centrifugation) 
g or gm gram/s 
GABA γ-aminobutyric acid 
GLP-1 glucagon like peptide-1 
GPCR G-protein coupled receptors 
HET Haus für Experimentelle Therapie 
HFD high-fat diet 
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i.p. intraperitoneal 
Kb kilobase 
kg kilogram 
KO knockout 
KOR kappa opioid receptor 
LH lateral hypothalamus 
M molar 
mg milligram 
min/s minute/s 
ml milliliter 
mM millimolar 
MOR mu opioid receptor 
MSN medium spiny neurons 
NAc nucleus accumbens 
ND normal diet 
ng nanogram 
nm nanometer 
NPY Neuropeptide –Y 
NTS nucleus tractus solitaris 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
PDYN prodynorphin 
PENK proekephalin 
PFA paraformaldehyde 
pH measure of acidity/basicity 
POMC proopiomelanocortin 
PR progressive ratio 
PVN paraventricular nucleus 
rev reverse  
RNA ribonucleic acid 
RT room temperature 
SEM standard error of mean 
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TE tris EDTA 
TR time-restricted 
v/w volume/weight 
VTA ventral tegmental area 
WHO World Health Organization 
WT wild-type 
wt weight 
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Summary 
 Endogenous opioids are involved in a broadly distributed neural network 
regulating eating behavior. Opioid transmission has long been implicated in 
controlling hedonic and homeostatic feeding as well as regulating body weight and 
metabolism. Most evidence implicating endogenous opioids is based on studies 
using pharmacological, or genetic knockout of opioid receptors, which alters 
feeding behaviors. However, individual contribution of each opioid peptide in 
feeding behavior and metabolism is not entirely clear.  
   The present study was aimed to distinguish the role of the two major 
classes of endogenous opioids, namely enkephalin and dynorphin, in the 
motivational aspect of feeding behavior. Prodynorphin knockout and 
proenkephalin knockout mouse models were presented with highly palatable 
chocolate-flavored pellets and tested in an operant-self administration paradigm. 
The results suggest that the endogenous peptides dynorphin and enkephalin are 
involved in the modulation of hedonic control of feeding behavior. The second aim 
of the study was to elucidate the impact of dynorphin in modulation in the body 
weight and metabolism after prolonged voluntary palatable high-fat food 
consumption. Prodynorphin deficient and wild-type mice were maintained for 12 
weeks on a high-fat diet (60% fat) or a normal chow with either a time-restricted 
access (8 hours) to food or an ad libitum access to food. The outcomes from the 
present study demonstrate the crucial role of endogenous opioid dynorphin in the 
regulation and maintenance of body weight. Blood glucose levels were modulated 
in high-fat diet-fed female mice, whereas, food consumption in animals was 
unaltered. Furthermore, prodynorphin deficient animals displayed significantly 
reduced levels of hypothalamic orexigenic peptides NPY and orexin-A under 
different feeding regimens. 
 The present study gives a first insight about the modulation of metabolic 
and endocrine changes associated with diet composition and feeding regimen by 
endogenous opioid dynorphin. The study also demonstrates the involvement of the 
opioid peptides dynorphin and enkephalin in hedonic control of feeding behavior. 
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1 Introduction 
1.1 Obesity 
 Obesity is currently one of the leading preventable diseases in the world. A 
number of population-based studies over the last few decades have demonstrated 
an increase in the percentage of overweight and obese humans. Consequently, 
there has been a remarkable rise in the obesity related health problems such as 
hypertension, diabetes, hypercholesterolemia, and liver disease (Wilborn et al., 
2005). The World Health Organization (WHO) considers obesity as “one of the 
greatest public health challenges of the 21st century”. The body mass index (BMI), 
also known as the Quetelet index, is a WHO accepted unit for classifying the degree 
of obesity. Standards defining overweight and obesity on the basis of BMI were 
developed by the International Obesity Task Force of the WHO (Nakajima, 1998). 
Obesity is defined as having a BMI of 30 kg/m2 or more. 
 The regulation of eating behaviors of palatable food is an important 
determinant of obesity. Three major factors that modulate body weight are 
metabolic factors, diet, and physical activity, each influenced by genetic traits 
(Weinsier, Hunter, Heini, Goran, & Sell, 1998). Although the driving causes are 
multifactorial, the fundamental cause of obesity and overweight is an energy 
imbalance between calories consumed and expended. Therefore, understanding 
the relation between energy balance and obesity is a challenge and a necessity to 
develop effective prevention programs and policies (Romieu et al., 2017). From an 
evolutionary perspective, eating is essential for survival and is underpinned by the 
fundamental physiological need to consume energy. However, we often consume 
excess of the basic nutrient and energy requirement needed to maintain 
physiological homeostasis, predominantly when there is an abundance of readily 
available food (Reichelt, Westbrook, & Morris, 2015). Food also differs from other 
addictive substances because it is legal and inexpensive. In combination with our 
innate preferences, these factors can be used to exploit the vulnerability in 
individuals and increase the probability of 'misuse' of food by overconsumption 
(Taylor, Curtis, & Davis, 2010). Repeated exposure to drugs of abuse can cause 
long-lasting effects in the neuronal circuitries and eventually induces loss of 
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control over its intake. However, the neural mechanisms underlying the 
motivation to eat and the rewarding effects of food altering the state of obesity are 
still largely undetermined, holding back the development of effective therapy. 
Therefore, it is important to understand these mechanisms by which these reward 
components induce adaptive changes in the neuronal circuitry responsible for 
addictive behaviors. 
 The brain reward systems plays a critical role in diet and feeding behavior 
of animals and humans (Lutter & Nestler, 2009; Saper, Chou, Elmquist, & 
Homeostasis, 2002). In general, bland tasting foods are not eaten in excess, 
whereas palatable foods are often consumed even after energy requirements have 
been met. Indeed, obtaining the pleasurable effects of palatable food is a powerful 
motivational force, that in certain individuals can override homeostatic signals (H. 
Zheng, N. Lenard, A. Shin, 2009; Shomaker et al., 2010). Most theories of feeding 
regulation propose that two parallel systems interact to influence food intake, the 
homeostatic and the hedonic system (Hommel et al., 2006). 
 
1.2 Homeostatic and hedonic system 
 Hedonic and homeostatic feeding pathways are complementary and 
regulate intake of food. The homeostatic pathway controls energy balance by 
increasing the motivation to eat following depletion of energy stores. In contrast, 
hedonic or reward-based regulation can override homeostatic pathway during 
periods of energy abundance by increasing the desire to consume food that is 
highly palatable (Lutter & Nestler, 2009).  
 On one hand, the homeostatic control of feeding system comprises of 
hormonal regulators of hunger, satiety, and adiposity levels, such as leptin, ghrelin, 
and insulin, which act on hypothalamic and brainstem neuronal circuits. These 
peripheral signals stimulate or inhibit feeding in order to maintain appropriate 
levels of energy balance. Dysfunction in components of homeostatic system can 
result in a persistent state of positive energy balance and the development of 
obesity (G F Koob & Le Moal, 2008). Therefore, homeostatic feeding is controlled 
primarily by neuronal circuits in the hypothalamus and brainstem, which relay 
information from peripheral signals of various circulating hormones, nutrients and 
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vagal afferents. The peripheral signals from the gut are crucial for control of 
appetite as well as regulation of energy- and glucose-homeostasis (Page, Symonds, 
Peiris, Blackshaw, & Young, 2012). Under the conditions of food deprivation, 
metabolic and neuronal signals are activated, which increase the motivation to eat. 
Hunger signals, such as ghrelin in the stomach and orexigenic peptides such as 
neuropeptide-Y (NPY) and agouti-related peptide (AgRP) in the hypothalamus, are 
suppressed after intake of standard food, while satiety signals like cholecystokinin 
(CCK), glucagon-like peptide-1 (GLP-1), peptide PYY, insulin and leptin are raised 
(Erlanson-Albertsson, 2005; Lindqvist et al., 2005). Once the energy needs of the 
body are met, the negative feedback mechanisms consequently reduce the 
motivation for consumption of food.  
 The hedonic control of feeding, on the other hand, mainly concerns with 
palatability and incentive properties of food. Palatable food induces resistance to 
several satiety signals resulting in overeating. The reward and motivational 
aspects of food are controlled by neurons in cortico-limbic regions (Nora D 
Volkow, Wang, & Baler, 2011). There is a substantial amount of evidence pointing 
to the fact that overconsumption of the highly palatable food can lead to 
alterations in the brain rewarding circuit, due to repeated stimulation of dopamine 
pathway, similar to the phenotype seen with drug addicts (Smith & Robbins, 2013; 
N. D. Volkow, Wang, Tomasi, & Baler, 2013). Neuronal circuits activated and 
modified by highly palatable food and drugs of abuse overlap. The neuronal and 
cellular mechanisms regulating the feeding behaviors are fundamentally similar to 
those engaged by drugs of addiction. Rewarding effects of food are indirectly 
mediated by various peripheral and central signaling pathways, whereas, drugs of 
abuse elicit direct effects on the reward circuit (Dileone, Taylor, & Picciotto, 2013; 
Rada, Avena, Barson, Hoebel, & Leibowitz, 2012; N. D. Volkow et al., 2013). Due to 
these similarities between drug addiction and food intake, many findings from 
drug research can be translated to obesity. 
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1.3 Brain reward circuit 
 The mesolimbic dopaminergic pathway, also known as the brain 'reward' 
circuit, comprises of dopamine neurons in the ventral tegmental area (VTA) 
projecting to the nucleus accumbens (NAc), where it mediates reward. Ingestion of 
palatable food activates the reward circuit, by release of dopamine in NAc, and 
therefore leading to a positive emotional state (Russo & Nestler, 2013). The VTA–
NAc reward circuit is crucial for the recognition of rewards in the environment and 
for initiating their consumption, as well as respond to aversive stimuli (Spanagel, 
R, Weiss, 1999). VTA dopamine neurons also innervate several other regions of the 
prefrontal cortex, central and basolateral amygdala as well as hippocampus (G F 
Koob & Le Moal, 2008; Russo & Nestler, 2013) (Fig. 1).  
 
 
 
 
 
 
 
 
Fig. 1. VTA-NAc reward circuit (adapted from Russo & Nestler, 2013) 
The mesolimbic dopaminergic pathway mediates brain reward signaling of dopamine 
projections (green) from the VTA to the NAc, Amy and mPFC. The dopamine release 
results in a positive emotional state, whereas GABAergic interneurons (blue) project their 
inhibitory effect. This feedback loop is functional via the participation of the endogenous 
opioid system. Other brain areas such as the lateral hypothalamus (LH) innervate the 
dopamine neurons on the VTA via glutamatergic projections (red). LH = lateral 
hypothalamus, NAc = nucleus accumbens, VTA = ventral tegmental area, Amy = amygdala, 
mPFC = medial prefrontal cortex. 
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 The majority of neurons that populate the NAc are the GABAergic (γ-
aminobutyric acid) medium spiny neurons (MSN) that receive extensive 
glutamatergic inputs from amygdala, hippocampus and prefrontal cortex 
(Bruijnzeel, 2010; Floresco, Blaha, Yang, & Phillips, 2001). The MSNs are divided 
into two classes - striatonigral cells containing substance P, dynorphin and D1 
receptors, and striatopallidal cells containing enkephalin and D2 receptors (Gerfen 
et al., 1990; Robison & Nestler, 2011). The activation of both types of dopamine 
receptors in the NAc is strongly correlated with behavioral performance in 
motivation-dependent paradigms as well as their strong responses to rewards 
(Bromberg-Martin, Ethan S., Matsumoto & Hikosaka, 2011; Soares-Cunha et al., 
2016). In the NAc, optogenetic stimulation of D1-type MSNs in mice enhanced 
cocaine-induced place conditioning and locomotor activation, whereas stimulation 
of D2-type MSNs had an opposite effect. Optogenetic stimulation of D1-type 
neurons in the dorsal striatum induced a persistent increase in operant lever 
pressing, whereas stimulation of D2-type neurons induced a transient decrease, 
indicating their involvement in motivational behavior with opposing functional 
roles (Kravitz, Tye, & Kreitzer, 2012; Lobo et al., 2011; Russo & Nestler, 2013). 
 Dopamine neurotransmission in the NAc is thought to mediate the 
motivational drive by the attribution of incentive salience (Box 1) to reward-
related stimuli, thereby facilitating behaviors directed towards specific goals such 
as food seeking and eating. 
 
Box 1. Incentive salience 
 
 
   
 
 
 
  
Food and food-related cues can activate different brain circuits involved in reward 
including NAc, hippocampus, amygdalda, prefrontal cortex and midbrain. It is 
believed that mesolimbic DA system promotes the learning of association between 
Incentive salience is a cognitive process, which confers a 'desire' or 'wanting' 
attribute including a motivational component to a rewarding stimulus. The "wanting" 
of incentive salience differs from "liking". Liking is the pleasure that is immediately 
gained from the consumption of a rewarding stimulus, whereas, "wanting" of 
incentive salience serves a motivational quality of a rewarding stimulus that makes it 
a desirable and attractive goal, transforming it from a mere sensory experience into 
something that commands attention, induces approach, and causes it to be sought out 
(Berridge, 1996). 
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natural rewards and the environment in which they are found (Dalley et al., 2005; 
Palmiter, 2007). Hence, these food-related cues promote the rapid firings of DA 
neurons, and facilitate behaviors directed towards acquisition of the reward (Baik, 
2013). Indeed, firing of these VTA dopamine neurons has been suggested to signal 
the difference between expected rewards and the actual outcome, which is also 
known as reward-prediction error (Boender et al., 2014; Cohen & Uchida, 2012; 
Steinberg et al., 2014). This signaling, involving the DA release in the NAc, has also 
been suggested to assign increasing reward value to food cues (Roitman, 2004). 
Rewarding stimuli associated with 'wanting' or 'liking' (i.e. pleasure or desire) 
function as positive reinforcers, which can be evaluated by paradigms such as 
operant conditioning (Sandeep Sharma, Hryhorczuk, & Fulton, 2012) (Box 2). 
Operant conditioning paradigm provides one of the most effective means to 
evaluate changes in the motivational properties of food.  
 
Box 2. Behavioral paradigm and terminologies 
 
 
 
 
 
   
  
 Besides dopamine, other neurotransmitter systems such as the endogenous 
opioid system and endocannabinoid system play a vital role in acute reinforcement 
and rewarding behavior. Endogenous opioids are postulated to be critical 
regulators of hedonic responses of food intake, which influence the activation of 
mesolimbic dopamine system (Hayward, Schaich-borg, Pintar, & Low, 2006). 
 
 
 
Operant conditioning is the learning process of association between behavior and 
its consequences, thereby strengthening or weakening the behavioral responses. It 
involves voluntary responses, in which the likelihood of a specific behavior 
increases or decreases in response to reinforcement or punishment that occurs 
when the behavior is exhibited, so that the subject comes to associate the behavior 
with the pleasure from the reinforcement or the displeasure from the punishment. 
Positive reinforcement is the process by which presentation of a stimulus, usually 
pleasant (e.g. palatable food or drug itself) increases the probability of a behavioral 
responding (G F Koob & Volkow, 2010). 
17 
 
1.4 Endogenous opioid system 
 The endogenous opioid family consists of three main classes of peptides - β-
endorphins, enkephalins and dynorphins and the three opioid receptors, mu 
(MOR), delta (DOR), and kappa (KOR), respectively. Opioid receptor family belongs 
to G-protein coupled receptors (GPCR), coupled to Gi/Go protein. Endogenous 
opioid peptides and receptors are broadly expressed throughout peripheral and 
central nervous system and have been a subject of intense investigation over the 
last several decades. Expression of opioid receptors is found primarily in brain 
regions such as cortex, limbic system, and the brain stem and immunoreactivity 
studies have shown a large overlap of the peptide projection fibers with the 
localization of the receptors (Merrer, 2009; Schwarzer, 2009).  
 The three endogenous opioid ligands - enkephalin, dynorphin, and ß-
endorphin are produced by proteolytic cleavage of large protein precursors known 
as preproenkephalin (PENK), preprodynorphin (PDYN), and proopiomelanocortin 
(POMC), respectively. PENK precursor protein is the most abundant and widely 
distributed, found in the thalamus, while PDYN is present in most brain structures 
with the highest concentration in the NAc. POMC distribution is restricted in most 
of the cortical structures although detected in arcuate nucleus, nucleus tractus 
solitarius (NTS, brain stem) and the anterior lobe of pituitary. All the opioid 
peptides share a common NH2-terminal Tyr-Gly-Gly-Phe signature sequence, 
which interacts with opioid receptors (Mansour, Fox, Akil, & Watson, 1995; 
Merrer, 2009). 
  Endogenous opioid receptors differ in their binding affinity for each 
receptor. Enkephalins have a high affinity for DOR and to a lesser extent for MOR, 
whereas β-endorphins activate both, MOR and DOR with similar affinities. 
Endogenous dynorphin exhibits the highest affinity exclusively for KOR (Clarke, 
Zimmer, Zimmer, Hill, & Kitchen, 2003)(Fig. 2).  
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Fig. 2. Endogenous opioids peptides, receptors their binding affinity 
β-endorphin activates MOR and DOR, respectively, with a high affinity. Enkephalin has a 
high affinity for DOR, whereas, dynorphin predominantly bind to KOR. MOR = mu opioid 
receptor, DOR = delta opioid receptor, KOR = kappa opioid receptor. 
 
 The endogenous opioid system modulates the rewarding circuitry through 
the receptors in VTA by influencing the activity of dopamine neurons. At the NAc 
level, it affects the dopamine release and activity of postsynaptic neurons. Opioid 
receptors in the dorsal striatum also contribute to hedonic mechanisms regulating 
feeding behaviors. Several studies have proved that pharmacological agonism or 
antagonism of opioid receptors, increased or decreased the food intake, 
respectively (Bodnar, 2004; M. Zhang, Gosnell, & Kelley, 1998). Opioid receptor 
antagonists such as naloxone and naltrexone attenuate both addictive drug taking 
and appetite for palatable food, whereas opioid agonists such as morphine or 
synthetic enkephalin analogues increase food consumption (Nogueiras, Maria, 
Novelle, López, & Diéguez, 2012). Synthetic compounds and natural rewards that 
activate the MOR or DOR opioid receptors generally have a positive motivational 
effects, whereas KOR opioid receptor agonists induce aversive effects 
(Shippenberg, Bals-Kubik, & Herz, 1987, 1993). These opposing pharmacological 
responses of opioid receptors reflect an opposite modulation of the reward 
circuitry (Fig. 3). 
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Fig. 3. Modulation of dopamine by endogenous opioid signaling (adapted and 
modified from Niikura et al., 2010). Endogenous opioid ß-endorphin or MOR agonist 
activates MOR and inhibit GABAergic neurons that normally inhibit dopaminergic neurons 
in the VTA. This disinhibition leads to an increase in dopamine release in the NAc. 
Endogenous opioid dynorphin activates the KOR in the NAc and acts as a 
countermodulatory system by decreasing the release of dopamine and the reward effects 
of MOR (bottom half: blue).    
 
1.5 Dynorphin 
 Dynorphins (DYN) are a class of opioid peptides that arise from the 
precursor protein prodynorphin (PDYN), which on cleavage produces active 
components - PDYN A and PDYN B and α/β-neo endorphins (Day, Lazure, Basak, & 
Boudreault, 1998). Even though the dynorphin peptide is found widely distributed 
in the central nervous system, the highest expression is found in hypothalamus, 
midbrain, medulla pons and spinal cord (Goldstein & Ghazarossian, 1980). 
Depending upon its site of production,  has increasingly been thought to play a 
crucial regulatory role in numerous functional pathways of the brain related to 
learning and memory, emotional control, stress response and pain and in 
modulation of reward-related processes (Goldstein & Ghazarossian, 1980; 
Schwarzer, 2009). Although dynorphin selectively activates the endogenous KOR, 
it is also known to bind to MOR and DOR with a very low affinity (S. Zhang et al., 
1998).  Conversely, the other opioid peptides, β-endorphin and enkephalin, poorly 
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interact with the KOR. Therefore, the DYN/KOR signaling pathway forms a distinct 
process within the opioid system (Goldstein A; Tachibana S; Lowney LI; 
Hunkapiller M; Hood L, 1979). The distribution of dynorphin closely matches that 
of KOR showing high concentrations in the NAc and hypothalamus (Fallon & Leslie, 
1986; Khachaturian, 1985). 
 Pharmacological activation of KOR in humans evokes reports of dysphoria 
and anxiety similar to those detected in rodent models (Millan, 1990; Pfeiffer, 
Brantl, & Herz, 1985). KOR activation in the dopamine neurons in VTA have been 
implicated in the aversive properties of the stress response (Bruchas, Land, & 
Chavkin, 2010; Van’t Veer & Carlezon, 2013). Pioneer studies from Di Chiara and 
Imperato demonstrated that KOR agonists inhibit dopamine release in the 
striatum, and suggested that dysphoria was a consequence of reduced dopamine 
tone. DYN/KOR signaling is known to negatively modulate the reward by 
decreasing the dopamine release in the striatum and increasing dopamine uptake 
(Di Chiara & Imperato, 1988; Thompson et al., 2000; Yokoo, Yamada, Yoshida, 
Tanaka, & Nishi, 1992). As a result, DYN/KOR signaling acts as a 
countermodulatory mechanism (negative feedback loop) of the mesolimbic 
dopaminergic reward circuit (Fig. 4).  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Fig. 4. DYN/KOR signaling (figure modified from Nestler, 2001) 
The DYN/KOR is a negative feedback mechanism modulating the dopamine release. DYN 
on synthesis via the cAMP-CREB cycle, is released from the terminals of the NAc neurons, 
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act on the KOR located on the nerve terminals and cell bodies of dopamine (DA) neurons 
of VTA, to inhibit their functioning (Nestler, 2001). DYN = dynorphin, DR = dopamine 
receptor, OR = opioid receptor, VTA = ventral tegmental area, NAc = nucleus accumbens, 
cAMP = cyclic adenosine monophosphate, CREB = cAMP response element binding 
protein, GABA = ϒ- amino butyric acid. 
 
 Over the past few years, refinement of pharmacological tools and 
availability of genetic approaches in animal studies have clarified the specific role 
of each opioid ligand and receptor in several aspects of opioid-related behaviors 
(Pradhan, Befort, Nozaki, Gaveriaux-Ruff, & Kieffer, 2011). The generation of 
prodynorphin deficient mice has facilitated us to investigate open questions on 
network effects of endogenous dynorphin. So far, three research groups have 
generated prodynorphin deficient mouse models (Loacker, Sayyah, Wittmann, 
Herzog, & Schwarzer, 2007; Sharifi, Diehl, Yaswen, Brennan, & Hochgeschwender, 
2001; Zimmer et al., 2001). PDYN deficient mice exhibit phenotype of moderate 
enhancement of anxiety related behaviors and most striking deficits in the 
extinction of conditioned fear responses. The effects of drugs of abuse in PDYN KO 
mice increased locomotor sensitization to cocaine, whereas, reduced aversive 
responses to cannabinoids and nicotine self-administration, while altered stress 
responses in long-term ethanol exposure (Galeote, Berrendero, Bura, Zimmer, & 
Maldonado, 2009; Mendizábal, Zimmer, & Maldonado, 2006; Rácz, Markert, Mauer, 
Stoffel-wagner, & Zimmer, 2012; Zimmer et al., 2001). In case of natural rewards, 
operant reinstatement of food-seeking behavior in mice showed a reduction in the 
prodynorphin mRNA levels (Martín-garcía, Burokas, Kostrzewa, & Gieryk, 2011). 
In humans, the PDYN polymorphism modulates neural processes associated with 
the anticipation of rewards (Votinov et al., 2014). However, due to the complexity 
of the endogenous opioid system, the exact role of dynorphin in palatable reward-
driven behavior still needs to be thoroughly investigated. 
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1.6 Enkephalin  
 The opioid precursor proenkephalin (PENK) is enzymatically cleaved into 
leu-enkephalin, met-enkepahalin, and two-carboxyl (C)-terminally extended met-
enkephalins (Weisinger, 1995). PENK is widely expressed in the brain regions 
involved in reward and reinforcement. PENK positive neurons have been detected 
in the bed nucleus of the stria terminalis, the central nucleus of the amygdala, the 
caudate putamen, and various hypothalamic nuclei including the paraventricular 
hypothalamic nucleus (Sukhov, Walker, Rance, Price, & Young III, 1995).  
Studies from PENK deficient mice have demonstrated the phenotype of 
increased anxiety, aggressive behaviors and abnormal stress responses (Bilkei-
Gorzo, Racz, Michel, Zimmer, & Klingmüller, 2004; König, Zimmer, Steiner, Holmes, 
& Crawley, Jacqueline, Brownstein, Michael J., Zimmer, 1996). Enkephalin has also 
been known to participate in the reinforcing properties of drugs of abuse. PENK 
deficient mice exhibit unaltered ethanol preference, no stress-induced elevation of 
alcohol consumption or no nicotine-conditioned place preference, as well as 
decreased nicotine-induced release of dopamine in NAc (Berrendero, 2005; Bilkei-
Gorzo et al., 2008; Bilkei-Gorzo, Racz, Michel, Zimmer, Klingmüller, et al., 2004; 
König et al., 1996; Racz et al., 2009; Valverde, Maldonado, Valjent, Zimmer, & 
Zimmer, 2000).  
Exposure to alcohol is also known to influence the endogenous opioid 
peptide expression and alters opioid peptide release in distinct brain regions 
associated with reward and reinforcement (Gianoulakis, 2004; George F. Koob, 
Sanna, & Bloom, 1998; R Spanagel, Herz, & Shippenberg, 1992). In case of natural 
rewards, PENK deficient mice with access to sucrose solution exhibited fewer 
bouts than WT controls, indicating diminished motivation for food. On the 
contrary, consumption of palatable chocolate in rats led to an upsurge in levels of 
enkephalin in the dorsal striatum, a region implicated in the reward-related 
functions (Difeliceantonio, Mabrouk, Kennedy, & Berridge, 2012; Mendez, Ostlund, 
Maidment, & Murphy, 2015).  This effect was observed only in enkephalin levels, as 
dynorphin levels were unaltered. Taken together, these studies suggest a vital role 
of enkephalin peptide in the modulation of food reward and motivational behavior. 
Recently, a floxed PENK locus was generated, in our laboratory to investigate the 
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role of enkephalin signaling in specific neuronal cells (Dr. Britta Schürmann, PhD 
thesis). The floxed locus contains a lacZ gene, downstream of the enkephalin 
coding exon. The introduction of the loxP into the genome allows the subsequent 
excision of embedded region via cre-recombinase mediated recombination, which 
enables the tissue- or cell-specific deletion of the corresponding gene. Schematic 
representation of the floxed PENK locus is depicted in Fig. 5. 
 
 
Fig. 5. Schematic representation of floxed proenkephalin gene locus 
Exons 1, 2, and 3 are indicated in blue boxes, loxP sites are indicated with pink triangles 
and lacZ gene indicated by a brown box. Cre-mediated recombination results in the 
excision of exons 2 and 3 and activation of lacZ reporter gene. 
 
 
1.7 Preference for food and diet-induced obesity 
 Endogenous opioids are thought to modulate the reward circuitry based on 
food preferences in humans as well as animals. In humans, opioid receptor 
antagonism has shown to reduce high-fat diet consumption along with decrease in 
preference for sucrose (Nogueiras et al., 2012). In animals, the role of the opioid 
system in the modulation of food preference has mostly been studied using 
pharmacological methods and opioid receptor knockout mice. Generally, opioid 
receptor agonists are known to increase food consumption, whereas opioid 
antagonists decrease food consumption. This idea is supported by several studies 
conducted by administration of opioid receptor agonists or antagonists targeted in 
particular brain sites. The administration of MOR agonists in NAc  caused an 
enhanced “liking” reactions to sweet pleasure and that stimulate food intake 
(Pecina, 2005). Administration of opioid antagonist naltrexone into a central 
amygdala, a reward-related site, resulted in inhibition of  intake of 'preferred diet' 
such as high-fat or high-sugar (and in another experiment chocolate or banana 
flavor), when presented alone. However, when both diets were presented together, 
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only preferred food intake was stimulated in animal. Therefore, opioids seem to 
modulate flavor-based preferences in food consumption. (Naleid, Grace, 
Chimukangara, Billington, & Levine, 2007; Woolley, Lee, & Fields, 2006). 
Furthermore, naltrexone inhibits food consumption in mice regardless of its 
hedonic value after injection into the hypothalamic paraventricular nucleus (Glass, 
Billington, & Levine, 2000; Olszewski, Alsiö, Schiöth, & Levine, 2011). Collectively, 
data from previous studies have also suggested that opioid regulation of palatable 
food intake is independent from its nutritional value.  
 It has been shown that the development of obesity and associated metabolic 
changes depends on the nutrient content of the high-fat diet, as well as the context 
and timing of the food presentation (Conlon & Bird, 2015). Furthermore, the 
gender also plays an important on feeding behaviors and physiological changes 
associated with the development of obesity (Meyer, Clegg, Prossnitz, & Barton, 
2012). Previously opioid peptide knockouts have also demonstrated sex-specific 
phenotypes in case of ethanol preference (Racz et al., 2009). With regards to 
consumption of a high-fat diet, endogenous opioids and receptors such as MOR, 
has been implicated as a critical factor. Direct stimulation of the MOR by an agonist 
in NAc, specifically stimulated the consumption of high-fat food in rats (M. Zhang et 
al., 1998). Chronic consumption of palatable high-fat diet in mice has also shown to 
increase anxiety- and depressive-like behavior, heighten the HPA response to 
stress and is responsible for several biochemical modifications in brain reward 
circuitry (S Sharma, Fernandes, & Fulton, 2013; Singh, 2014). There are a number 
of animal models of obesity generated so far by genetic engineering, 
pharmacological treatments or different diets to induce obesity (Lutz & Woods, 
2012). The mouse model of diet-induced obesity (DIO) has become one of the most 
important tools for understanding the interplay of high-fat Western diets and the 
development of obesity. The DIO model closely mimics the increasingly availability 
of the high-fat foods in modern society, which are main contributors to the obesity 
trend in human (Wang & Liao 2012).  
 It has been postulated that opioid signaling also contribute to binge-eating 
phenomenon in animals and humans (Blasio, Steardo, Sabino, & Cottone, 2013; 
Chamberlain et al., 2012). Research from Corwin, Avena, & Boggiano illustrated 
three models of binge-eating: i) a model of sugar-bingeing in which animals with 
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repeated intermittent access to a sugar solution developed behaviors and brain 
changes that were similar to the effects of some drugs of abuse, ii) model with 
history of dieting and stress that could perpetuate further binge-eating of palatable 
and non-palatable food, iii) limited access model in which non-food deprived rats 
with sporadic limited access to a HFD develop binge-type behaviors (Corwin, 
Avena, & Boggiano, 2011). Crucial differences between animal and human binge 
eating include the fact that subjective feelings of distress or loss of control, which 
have been found in some but not all studies linked prospectively to binge episodes 
in humans, are not easily assessed in animals (Mathes, Brownley, Mo, & Bulik, 
2009). 
  Recent research using the limited access protocol has revealed that mice 
are partially protected against the metabolic effects of the HFD under a time-
restricted feeding condition, showing no signs of hyperinsulinemia, hepatic 
steatosis, or inflammation (Hatori et al., 2012). Therefore, the limited access or 
restricted access to feeding regimen enables us to differentiate between the direct 
effects of HFD on brain functions and its indirect effects via metabolic changes. 
Now, the question arises whether the consumption of HFD is sufficient to change 
the feeding behaviors by modulating the reward circuitry? or whether  metabolic 
changes induced by the HFD are crucial in the neuronal modulation of reward or 
not? To clarify these uncertainties, investigations need to be performed taking into 
account several factors such as diet, feeding regimen as well as sex at the same 
time.  
 
1.8 Hypothalamus: homeostatic regulation of feeding 
  The main brain structure that controls the regulatory signals for food 
consumption in homeostatic control of feeding is the hypothalamus (Martín-garcía 
et al., 2011). Hypothalamus is involved in the regulation of feeding, satiety, and 
energy homeostasis. It plays a key role in the control of food intake by sensing 
metabolic signals from peripheral organs and modulating these feeding behaviors. 
On interaction with other brain areas such as the brainstem and reward-related 
limbic pathways, the hypothalamus mediates regulation of short-term and long-
term dietary intake via synthesis of various orexigenic and anorexogenic 
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neuropeptides. The neuropeptides, which are present in the hypothalamus and are 
involved in regulating food intake, also play a key role in regulating glucose 
metabolism and energy expenditure (Heijboer et al., 2006). 
Within the hypothalamus, there are complex interactions between many 
nuclei of which the arcuate nucleus (ARC) is considered one of the most important 
hypothalamic centers that regulate food intake. ARC acts as a feeding control 
centre and integrates hormonal signal for energy homeostasis. ARC encloses the 
third ventricle and lies directly above the median eminence, which allows the entry 
specifically for peripheral peptides including leptin and insulin (Arora & Anubhuti, 
2006; Schwartz et al., 1992). ARC contains two distinct populations of neurons: 
orexigenic neuropeptide NPY, AgRP neurons and anorexigenic POMC neurons. The 
orexigenic neuropeptides such as NPY and orexins/hypocretins, which project to 
the paraventricular nucleus (PVN) and the lateral hypothalamus (LH), to act on 
local neurons to affect food intake and energy homeostasis (Elmquist, Elias, & 
Saper, 1999). 
NPY exhibits a variety of biological and physiological actions including 
modulation of feeding, thermoregulation, locomotor activity, cardiovascular 
function, cognition and memory, and stress-related behaviors (Bi, 2007; Colmers 
and Wahlestedt, 1993; Gray and Morley, 1986,Sheng Bi 2012) It is known that 
dorsomedial hypothalamic NPY expression is enhanced in rodent models of 
obesity with chronic food restriction (Bi, Robinson, & Moran, 2003). Opioid 
peptide dynorphin is also important in maintaining homeostasis through appetite 
control (Przewłocki, Gramsch, Pasi, & Herz, 1983). Dynorphin expressing neurons 
in ARC also contained NPY mRNA, with a co-localization in the lateral and dorsal 
part of the Arc, suggesting potential overlapping functions of these two 
neurotransmitters in feeding type behavior (Lin et al., 2006). Previous studies in 
rodents have shown that food deprivation results in a significant increase of NPY, 
which is co-localized with PDYN mRNA, in the hypothalamus (Przewłocki, 
Gramsch, Pasi, & Herz, 1983), whereas in PDYN KO mice, the expression of NPY 
was found to be downregulated (Lin et al., 2006) (Fig. 6).   
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Fig. 6. Effect of dynorphin knockout on hypothalamic NPY expression. (adapted from 
Lin et al 2006) NPY mRNA levels in the hypothalamic arcuate nucleus of wild-type (A) vs. 
dynorphin knockout (B) mice. Scale bar, 40 m, Dyn-/- = dynorphin knockout, 3V = third 
cerebral ventricle; Arc = arcuate nucleus of the hypothalamus. 
Another important brain structure is the lateral hypothalamus (LH), which 
is innervated by several orexigenic peptides such as orexin-A, orexin-B, melanin 
concentration hormone (MCH) and galanin. These neuropeptide cell populations 
are important in regulation of feeding and reward as well as metabolism through 
their neuronal circuitry. Orexins/ hypocretins are neuropeptides that are 
exclusively produced in LH, projecting to the ARC (Date et al., 1999; Horvath, 
Diano, & Pol, 1999). Orexins regulate appetite along with arousal and wakefulness 
and orexigenic neurons are regulated by peripheral metabolic cues, including 
ghrelin, leptin, and glucose concentration linking energy homeostasis to arousal 
state. Intracerebroventricular injections of orexins in rodents induce feeding 
behavior during the light period (Edwards et al., 1999; Haynes et al., 2000; Tsujino 
& Sakurai, 2013). A blockade orexin signaling with the orexin-1 receptor 
antagonist reduced acute HFD consumption. Acute HFD consumption thus requires 
orexin signaling (Valdivia, Patrone, Reynaldo, & Perello, 2014).  
Orexin signaling role in reward seeking behavior is well established, where 
it promotes drug-induced plasticity of glutamatergic synapses onto DA neurons of 
VTA, involved in motivated behaviors (Harris, Wimmer, & Aston-Jones, 2005). 
Double-labeled in situ hybridization studies indicated high levels of co-localization 
of orexin-A neuropeptide and dynorphin in rodents. Hence, orexin facilitates 
reward by attenuating the anti-reward effects of co-expressed dynorphin in the 
VTA of mice during cocaine self-administration (Muschamp, Hollander, Thompson, 
Voren, & Hassinger, 2014). However, their interaction in natural reward-seeking 
behavior such as highly palatable food still remains unknown. 
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1.9 Aim of the study 
 The present study focuses mainly on two members of the endogenous 
opioid peptide family, dynorphin and enkephalin, which preferentially bind to the 
opioid receptors KOR and DOR, respectively. Enkephalin peptide modulates the 
brain rewarding circuit by activating the DOR and increasing the release of 
dopamine in NAc, therefore mediating a positive rewarding effect. Conversely, 
dynorphin on activating the KOR reduces the dopamine release and negatively 
modulates the rewarding effect.  
 One aim of the study was to elucidate the involvement of dynorphin and 
enkephalin peptides in the palatable diet-induced rewarding behavior. It is 
hypothesized that knockout of proenkephalin (PENK KO) will result in decreased 
rewarding effect and consequently lowered motivation in mice to obtain highly 
palatable food reward. In contrast, knockout of prodynorphin (PDYN KO) will 
result in the increased rewarding effect and therefore increased motivation 
responses to obtain the highly palatable food reward. To test the hypothesis, 
constitutive PDYN KO and PENK KO mice and the controls (wild-type and floxed 
mice, respectively) were evaluated for their motivational behavior in an operant 
conditioning paradigm.  
 Another aim of the study was to identify the role of dynorphin in the 
modulation of metabolic changes associated with diet composition and feeding 
regimen. Prolonged voluntary consumption of a high-fat palatable diet, leading to 
obesity, produces alterations in the opioid signaling and hedonic aspects of feeding 
behavior. Therefore, it is hypothesized that mice lacking dynorphin will show an 
increased feeding behavior of palatable high-fat diet and alterations in the body 
weight and metabolism. To test this hypothesis, PDYN KO and wild type mice were 
exposed to either a normal diet or a high-fat diet for a period of 12-weeks, and 
were enabled either a time-restricted or an ad libitum access to food.  
  Hypothalamic orexigenic peptides together with opioid signaling 
mechanisms orchestrate the homeostatic feeding behavior. Therefore, changes in 
expression of hypothalamic orexigenic peptides after prolonged voluntary 
palatable high-fat diet consumption were analyzed in brain samples by 
immunohistochemistry.  
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2 Material and Methods 
2.1 Equipment 
Table 1. List of technical equipment 
Technical instrument 
Identifier, Company 
analytical balance BP 121 S, Sartorius 
animal tracking software EthoVision® XT, Noldus 
Bioanalyzer 
Agilent 2100 bioanalyzer, Agilent 
Technologies 
CCD camera AxioCam MR, Zeiss  
centrifuges Biofuge fresco, Heraeus Instruments 
ChemiDoc gel imaging  
MP imaging systems, Bio-Rad 
Laboratories 
Cryostat CM3050S, Leica GmbH 
glucose meter  
Accu-Check Aviva, Roche Diagnostics 
GmbH 
laser scanning microscope SP8, DMI 6000 CS, Leica 
microscopes 
Eclipse TS 1000, Nikon 
Axiovert 200 M fluorescent 
microscope, Zeiss 
Axioscope 40, Zeiss 
open-field test device 
Open-field ActiMot &VideoMot, TSE-
Systems 
operant conditioning System TSE Systems 
PCR iCycler Bio-Rad Laboratories 
pH meter inoLab 
Skinner Box/Operant box TSE Systems 
Superfrost Plus® slides Menzel-Gläser 
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2.2 Software 
Table 2. List of software 
Software 
Company 
AxioVision LE Carl Zeiss  
Ethovision  Noldus 
Graphpad Prism 6 GraphPad Software, Inc 
ImageJ Wayne Rasband 
Leica Application Suite Leica 
Mouse-E-Motion Infra-E-Motion 
SartoConnect Sartorius 
Statistika StatSoft, Inc.  
PhenoMaster Program TSE Systems 
VideoMot 2 TSE Systems 
Ethovision XT  Nodulus 
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2.3 Chemicals and reagents 
2.3.1 Chemicals 
Table 3. List of chemicals  
Chemicals 
Company 
Albumin bovine Fraction V, pH 7.0  
standard grade, lyophil. (BSA) 
Serva 
DAPI Fluoromount-G® SouthernBiotech 
Ethidium bromide solution (10 
mg/ml) 
Sigma-Aldrich 
Fluoromount-G® SouthernBiotech 
paraformaldehyde Sigma-Aldrich 
Tween20 Sigma-Aldrich 
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2.3.2 Buffers and reagents 
If not stated otherwise all buffers and solutions were prepared with dH2O 
and all chemicals were purchased from Applichem, Life Technologies, Merck, Carl 
Roth or Sigma-Aldrich. 
 
Table 4. List of reagents 
Buffers and Solutions Composition Application 
mouse tail lysis buffer 
100 mM Tris/HCl 
pH 8.0 
5 mM EDTA 
200 mM NaCl 
0.2% (w/v) SDS 
mouse tail lysis 
TE buffer 
10 mM Tris 
1 mM EDTA, 
pH 8.0 
DNA isolation 
4% PFA 4% (w/v) 
paraformaldehyde 
fixation of brain tissue 
2x SSC 
0.3 M NaCl 
30 mM Na-citrate dihydrate 
adjusted to pH 7.0 
immunohistochemistry 
TBS (Tris-buffered saline) 
50 mM Tris-HCl 
150 mM NaCl, p.H 7.5 
 
immunohistochemistry 
PBS (Phosphate buffered 
saline) 
1.44 g KH2PO4 
90 g NaCl 
4.21 g Na2HPO4 
immunohistochemistry 
permeabilization solution 0.5% Triton X-100 in PBS immunohistochemistry 
blocking solution 
1%BSA/PBS and 10% 
donkey serum 
1% BSA/PBS and 10% 
donkey serum 
immunohistochemistry 
anesthetic  
500 µl xylariem 
1000 µl ketamin 
8500 µl 0.9% (w/v) NaCl 
pre – perfusion  
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2.4  Antibodies 
Table 5. List of antibodies 
Antibody 
Host Dilution/s Identifier, Company 
NPY Rabbit 1:1000 ab30914, Abcam 
 
Orexin-A Rabbit 1:500 PC362, Millipore 
Anti-rabbit Alexa Fluor® 488 donkey 
1:1000 (NPY) 
1:1500 (orexin-A) 
 
 
 
A21206, Invitrogen 
 
2.5 Food pellets  
Table 6. List of food pellets 
Food pellets Identifier, Company  
standard (normal) pellets  
V1534, Ssniff Spezialdiäten GmbH 
high-fat diet soft pellets #F3282, Bio-serv, Plexx, Europe 
normal diet precision pellets #5TUM, TestDiet, USA 
chocolate-flavored precision pellets #F05301, Bioserv, Plexx, Europe 
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2.6 Animals 
In the present study, constitutive prodynorphin knockout and proenkephalin 
knockout (König et al., 1996; Zimmer et al., 2001), along with age-matched control 
littermates on a C57BL/6J genetic background were used. Wild-type and PENK 
floxed mice were used as controls for PDYN KO and PENK KO mice, respectively. 
Schematic representation of the PENK floxed mice is represented in Fig. 5. All the 
animals used in this study were of age group 10-12 weeks old. The mice were kept 
in a reverse light/dark cycle, lights off between (6.00 a.m. and 6.00 p.m.). Food and 
water was provided in all cages, under SFP conditions, unless otherwise specified. 
The housing conditions were maintained at 21 + 1°C and 55 + 10% relative 
humidity. All experimental procedures were complied with regulations for animal 
experimentation in Germany and approved by Landesamt für Natur, Umwelt und 
Verbraucherschutz in Nordrhein-Westfalen, Germany (Zimmer et al., 2001). All 
procedures were in compliance with national regulations and institutional 
guidelines. 
2.7 Behavior experiments 
2.7.1 Operant conditioning paradigm 
 The motivational responding in PDYN KO, PENK KO and the control animals 
was assessed in an operant conditioning paradigm. The animals were single-
housed for a week before the start of the experiment. Body weight and daily food 
intake was monitored during the habituation week (7 days before the start of the 
experiment) as well as during the operant conditioning. For assessment of 
motivational responding, two types of pellets were presented to the animals- 
either standard normal precision pellets or highly palatable chocolate-flavored 
precision pellet. The normal precision pellet formulation consisted of 0.79 kcal/g 
protein, 0.345 kcal/g fat, 2.162 kcal/g carbohydrate, with a total caloric value of 
3.3 kcal/g. The chocolate-flavored precision pellet, rendered more palatable to the 
mice, had a similar composition to the normal pellet: 0.74 kcal/g protein, 0.50 
kcal/g fat, 2.36 kcal/g carbohydrate with an addition of 2% unsweetened cacao 
constituting a total caloric value of 3.6 kcal/g (table 2.5). Two days prior to the 
start of the operant conditioning, mice were habituated to the either of the two 
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pellets, to prevent the potential influence of food neophobia on operant 
performance. Food pellets were presented only during the experimental sessions. 
Otherwise, animals were maintained on standard normal pellets for their daily 
food intake.  
2.7.2 Apparatus 
The instrumental responding for food was conducted in the operant 
chambers/boxes. Each operant chamber or ‘Skinner box’ is a sound and light-
attenuated box equipped with a food dispenser, two holes for the nose-poke task 
on each side of the food dispenser hole, a house light and a stimulus light. One of 
the nose-poke hole was randomly assigned as active hole/sensor whereas the 
other as inactive (Fig. 7).  
 
 
 
 
 
 
Fig.7. A. Operant conditioning system / Skinner box  (modified from TSE Systems) and 
B. two types of precision pellets used for the conditioning paradigm, chocolate-flavored 
precision pellets (left) and normal precision pellets (right). 
 
Mice were trained for 7 days a week in 30 minutes daily session to acquire 
instrumental responding for food. There were two groups of animals - one group 
responded only for normal precision pellets while the other group responded only 
for chocolate-flavored precision pellets in the operant box. Each training session 
started with a 2-seconds presentation of the yellow cue-light stimulus, located 
above the assigned active hole for nose-poke. Active poking in the correct hole 
resulted in delivery of a food pellet, followed by a confirmatory 1-second green 
pellet dispenser 
nose-poke hole 
 
cue-light stimulus 
Chocolate-flavored 
pellets 
Normal pellets 
A B 
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light stimulus after obtaining the food reward (Guegan et al., 2013). Nose-poke into 
the inactive hole had no consequences. A 10 seconds time-out interval was 
established after obtainment of each reinforcer, where the stimulus cue-light was 
off and no pellet was delivered upon sensor activation.  
2.7.3 Operant training schedules 
 Mice were trained to respond for food under the fixed ratio (FR) schedule of 
reinforcement, which consisted of a fixed number of pellet deliveries obtained for 
each active nose-pokes. Fixed- ratio 1 (FR1) consisted of one reward per correct 
active nose-poke responding. To acquire the skills for correct nose-poke task, mice 
were deprived to 80% of their average daily food intake during 
acquisition/learning phase. Hence, the first training schedule is referred to as 'FR1 
with food deprivation'. The criteria for acquisition of the operant conditioning 
schedule was achieved when mice maintained a stable responding with less than 
20% deviation from the mean of the total number of food pellets earned during 
three consecutive sessions (80% of stability), with at least 75% responding on the 
active nose-pokes, and a minimum of 10 pellets per session (Barbano, Castañé, 
Martín-garcía, & Maldonado, 2009). Once the acquisition criteria were achieved, 
the animals were shifted to the subsequent fixed-ratio schedule of reinforcement. 
Animals that did not reach the criteria until 15 days of each training schedule were 
omitted from the experiment. 
 In the second reinforcement schedule, mice were given ad libitum (AL) 
access to food in their cages (FR1 AL). The motivational aspect of animals was 
assessed by instrumental responding for obtain palatable food, in satiated 
conditions. The successive operant schedules of reinforcements consisted of FR3 
(three active response led to one food pellet delivery) followed by FR5 (five 
correct responses led to one food pellet delivery) to evaluate the increase in 
motivation of mice for obtaining palatable food, on increasing complexity in 
reinforcement schedules. All the animals had an AL access to food during FR3 and 
FR5 schedules. The mean values and standard error or mean (SEM) of nose-pokes 
was recorded daily. 
Lastly, the animals were trained under the progressive ratio (PR) schedule of 
reinforcement. PR is a commonly used measure of reward strength in an operant 
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procedure and a well-validated unit to assess hedonic control of feeding behavior 
in rodents (Baldo et al., 2013; Brunzell et al., 2006; Papaleo, Kieffer, Tabarin, & 
Contarino, 2007). The objective of the PR is to escalate the response ratios until the 
animal no longer responds. The number of correct sensor responses made to 
achieve the last reward or response is called as the breakpoint (BP), which reflects 
the maximum effort the animal will expend in order to receive the food rewards 
(Hodos, 1961; Sandeep Sharma et al., 2012). Under PR schedule, the responses can 
be calculated as per Richardson and Roberts using the following formula 
P      e(  0.2) - , where, R = number of food rewards already earned plus 
1(Richardson & Roberts, 1996). PR is usually rounded up to the nearest integer. 
Thus, the number of responses required to earn a food reward follow the order: 1, 
2, 4, 6, 9, 12, 15, 20, 25, 32, 40, 50, 62, 77, 95 and so on. Each PR session lasted for 
an hour. The data were analyzed using the non-parametric Mann-Whitney U test. 
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2.8 Monitoring body weight and metabolism 
 To evaluate the metabolic changes, PDYN KO and WT control mice were 
maintained on a 12-week long high-fat diet or normal diet regimen, with either ad 
libitum or time restricted access to food. The mice were categorized into 4 main 
groups of diet and feeding in both sexes (Table 6). During the 12-week feeding 
regimen, body weight, blood glucose levels and food intake was monitored. 
 
Table 6. Diet and feeding schedules  
 
 
 
 
 
 
 
2.8.1 Body weight and food consumption 
 Body weight and food intake of mice maintained on a HFD or a ND, were 
monitored twice per week i.e. on the first and third day of every week. 
Additionally, for the TR feeding groups, the food was also weighed in the evening 
on these two days, at the end of their 8 hours of daily feeding regimen. The amount 
of food left in the cages was subtracted from the prior food value recorded, to 
evaluate the amount of food consumed by each cage. Pellets smaller than 
approximately 5 mm in size were recorded, and later removed to avoid spillage 
and inaccuracy in the food weight measurement. Data from male mice and female 
mice were calculated separately.   
Diet Feeding schedule Gender 
Normal (ND) 
time-restricted 
(TR) 
Males 
Female 
Normal ad libitum (AL) 
Males 
Female 
High-fat (HFD) time-restricted  
Males 
Female 
High-fat ad libitum  
Males 
Female 
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2.8.2 Blood glucose levels  
 For monitoring the blood glucose levels, mice were starved overnight 
before the test, to avoid nocturnal consumption and reduce the variability in 
baseline blood glucose(Ayala et al., 2010). Standard normal diet pellets and high-
fat diet soft pellets were removed from all cages on the previous day evening, and 
on the following day morning, blood glucose levels were measured using a fine 
syringe needle (23G). The tail vein was pricked, a drop of blood was collected onto 
the glucose test strip and measured using portable glucose meter. Food was then 
added back into all the cages. Blood glucose levels were recorded on week 4, 6, 8, 
10 and 12.  
2.9 Molecular Analysis 
2.9.1 Brain and organ dissection 
 Animals were anaesthetized by injecting the narcotic solution 
intraperitonially (i.p.) and were fixed onto a grid plate lying on their back. The 
thorax and abdomen were opened and transcardially perfused with 1X PBS, 
followed by ice-cold 4% PFA/PBS (4 ml/min). After fixation, the brain was 
carefully dissected and post-fixed overnight in 4% PFA/PBS at 4°C. On the 
following day, the PFA solution was changed with a 10% (w/v) sucrose solution 
for the next 24 hours, and then to 20% (w/v) sucrose solution for another 24 
hours. Brains were snap-frozen in ice-cold isopentane and stored in cryovials at -
80°C until further use. 
2.9.2 Immunohistochemistry 
 Perfused, snap-frozen brains were embedded in TissueTek®. Coronal slices 
of 16 µm thickness were cut using a cryostat and dried at 37°C for 30 minutes on a 
heating plate. The glass slides were labeled and stored at -80°C until use. Brain 
slices were marked with a PapPen and dried at 37°C for 30 minutes on a heating 
plate. The slides were rinsed with 1X PBS at room temperature (RT) for 5 minutes 
and permeabilized with 0.5%Triton X-100 in 1X PBS for 1 hour. The slices were 
then washed twice for 10 minute each, with 1X PBS and blocked with 1% BSA/PBS 
and 10% donkey serum for 1 hour in a humid chamber. Primary antibody were 
applied to slices, except for the negative controls, in which case, 3% BSA/PBS was 
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applied, and incubated at 4°C overnight. On the following day, the slices were 
incubated at 37°C for 2 hours, prior to washing steps. The slices were then washed 
3 times with 1X PBS for 10 minutes each. Anti-rabbit Alexa Fluor® 488 was 
applied as a secondary antibody and slices were incubated for 1 hour at RT in dark 
conditions. The slices were washed for 4 times with 1X PBS for 10 minutes each 
and briefly immersed for in H2O. Subsequently, immunostained brain slices were 
embedded in Fluoromount-G® media and carefully covered with glass coverslips. 
The sides of the slides were secured by sealing with nail polish and left to dry 
overnight and stored at 4°C.  
 
2.10 Image acquisition and signal intensity analysis  
 Images were observed under Zeiss Axiovert 200M fluorescent microscope 
with 10X objective lenses. For quantification of immunostaining, the region of 
interest was identified in accordance with the mouse brain Atlas (Paxinos G. & 
Franklin K.B.J., 2001). For hypothalamic peptide NPY, a threshold value was set for 
determining signal intensity and measured using ImageJ software (Version 1.50i, 
NIH, USA). In case of orexin-A expression, integrated signal density was measured 
using ImageJ. Hypothalamic peptide expression patterns in the arcuate nucleus 
(ARC) for NPY and lateral hypothalamus (LH) for orexin-A, respectively, were 
defined using a free-hand selection (Fig. 8). 
 
 
 
 
 
 
 
Fig. 8. Coronal section of brain representing areas of hypothalamic peptide 
expression. NPY is expressed in the arcuate nucleus (ARC) and neuropeptide orexin-A is 
expressed in the lateral hypothalamus (LH). (Fig. modified from Allen’s brain 
Atlas)(Sunkin et al., 2013). 
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2.11 DNA isolation, purification, and measurement 
 For genotyping of PDYN KO and WT mice, a 2 mm piece of the mouse-tail tip 
was cut and incubated in lysis buffer with proteinase K (1 mg/ml) at 45°C on an 
agitating shaker (550 rpm) overnight. The samples were centrifuged at 12000 g 
for 10 minutes and the supernatant was transferred into a fresh tube. Equal 
volume of isopropanol was added to precipitate the DNA. The DNA pellet was 
washed at 12000 g for 3 times, 10 minutes each, with 70% ethanol and air-dried 
for approximately 15 minutes. The pellet was dissolved in 100µl TE buffer. The 
concentration of DNA was determined by using a spectrophotometer. The 
absorbance wavelength of DNA (A260) of 1 unit was equivalent to 50 µl/ml of DNA 
concentration. Hence, the purity of a DNA preparation was assessed by the ratio of 
absorbance at 260/280 nm.  
2.12 Agarose gel electrophoresis 
 Agarose gel electrophoresis was performed for separation of DNA 
fragments from PCR reactions, to confirm genotyping. One percent agarose gel in 
TAE buffer was used to test samples in an electrophoresis chamber filled with TAE 
buffer. The sample run time usually lasted 30 minutes at 120 V. To estimate the 
size of DNA fragments, a 1 kb Plus DNA ladder was used as a unit of measure. 
Agarose gel containing DNA fragments was stained with ethidium bromide by 
incubation in an ethidium bromide bath for 20 minutes. Stained DNA fragments 
were detected using ChemiDoc MP imaging system. 
 
2.13 PCR for genotyping 
For the genotyping of PDYN KO mice, a polymerase chain reaction (PCR) was 
performed. Each PCR was specifically optimized to the oligonucleotide 
temperature requirements and length of the desired product. All PCR reactions 
were performed using GoTaq® Green Master Mix (Promega). The components of 
master mix consisted of Taq polymerase, dNTPs, MgCl2 and reaction buffers. The 
wild type allele led to a PCR product of 290 bp, whereas the knockout allele yielded 
a 500 bp fragment (table 7). 
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2.14 Statistical analysis 
 Statistical calculations were performed using STATISTICA software 
package. Datasets containing three independent variables were analyzed by a 
three-way ANOVA (treatment, genotype and sex) whereas dataset containing two 
independent variables (treatment and genotype) were analyzed by two-way 
analysis of variance (ANOVA). Analysis of the area under the curve (AUC) by two-
way ANOVA was used to determine significant differences in body weight, and 
glucose levels (genotype, and feeding as main effect, whereas time as within 
effect). Post-hoc Tukey’s test was applied with significance observed at p < 0.0 . 
Data for males and females were analyzed separately. Repeated measures of 
ANOVA were used when the data from the same animal was collected over a 
period of time (within effect: time). Hypothalamic peptide expressions were 
analyzed by two-way ANOVA. For non-parametric datasets Mann-Whitney U test 
was performed. The data are presented as the mean ± standard error of the mean 
(SEM) for all measurements. All graphical data was prepared using GraphPad 
Prism (version 6, La Jolla California USA) software. A value of p < 0.05 is denoted 
with *, p < 0.01 is denoted with **, p < 0.001 is denoted with *** and p < 0.0001 is 
denoted with ****. 
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Table 7. Primer sequence and PCR program for PDYN KO mice 
 
 
 
 
 
 
Primer sequence 
PDYN common (D25R) 
CTT CAG AAT AGG TAT TGG GGT TCT CCT 
GGG 
PDYN KO (Neo3) AGC GCA TCG CCT TCT ATC GCC TTC TT 
PDYN WT (D27) 
CGC ACC GTC CAT TTT AAT GAG GAG GAC 
TTG 
PCR reaction for PDYN KO genotyping 
sterile water 16 µl 
P1: KO PCR PDYN KO fwd   1 µl 
P2: KO PCR PDYN KO rev   1 µl 
P3: KO_PCR_WT   1 µl 
GoTaq®Green Master Mix 10 µl 
mouse tail DNA (100-150 ng/µl)   1 µl 
PCR program 
1 x initial 
denaturation 
95 °C 2 min 
Denaturation 95 °C 30 s 
35X annealing 60 °C 45 s 
Elongation 72 °C 60 s 
1 x final elongation 72 °C 5 min 
Cooling 4 °C ∞ 
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3 Results 
 The results section illustrates the outcomes of hedonic control of feeding 
behavior in endogenous opioid peptide knockout mouse models. Constitutive 
PDYN KO and PENK KO mice were tested for voluntary reward-related 
motivational responses for highly palatable 'chocolate-flavored' food rewards and 
normal food rewards in an operant conditioning paradigm. Next, to elucidate the 
role of endogenous opioid dynorphin in regulation of food intake and energy 
homeostasis, mice maintained on a high-caloric diet or a normal diet for 12 weeks 
were monitored for their metabolic changes. Furthermore, modulation in the 
hypothalamic peptides involved in the homeostatic feeding behavior was 
monitored by immunohistochemistry. 
3.1 Acquisition and maintenance of operant responding 
3.1.1 Operant motivational responding in PDYN KO and WT mice 
 PDYN KO and WT mice were tested for their motivational behavior, where 
animals either responded for a highly palatable chocolate-flavored pellet or a 
standard normal pellet in the operant conditioning paradigm.  
 Under the FR1 schedule of operant conditioning, under food deprivation 
conditions, a significant effect of pellet preference (F (1, 46) = 4.1797, p = 0.04), 
however no sex effect and no interaction were observed. Additionally, significant 
interaction effects were observed with respect to time, where time x pellet (F (7,322) = 
8.2112, p < 0.0001), time x genotype (F (7,322) = 2.4058, p = 0.02), time x sex (F (7, 322) 
= 3.35, p = 0.001) effects were observed. Both, PDYN KO and WT control mice 
displayed a significantly higher preference for chocolate-flavored pellets over 
standard normal pellets. WT males responded to chocolate-flavored pellets 
significantly higher than PDYN KO males, whereas, this effect was absent in female 
mice (Fig. 9A & B). Under FR1 AL schedule, a significant effect of pellet preference (F 
(1,44) = 16.01, p = 0.0002), genotype (F (1,44) = 9.02, p = 0.003), sex (F(1,44) = 14.56, p = 
0.0004), as well as pellet x genotype interaction (F (1,44) = 9.02, p = 0.003). 
Furthermore, significant interactions of time x pellet (F (9,396) = 2.20, p = 0.021) and 
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time x genotype (F (9,396) = 2.02, p = 0.035) were observed. WT mice displayed a 
significantly higher preference for chocolate-flavored pellets than normal pellets. 
Furthermore, WT female mice also showed a significantly higher preference 
(motivation) compared to PDYN KO female mice to obtain the highly palatable 
chocolate-flavored pellets. In general, the female mice had higher operant responses 
as compared to male mice (Fig. 9C & D). Next, under the FR3 schedule of 
reinforcement, significant effects were observed in pellet (F (1,42) = 17.1022, p = 
0.0001), genotype (F (1,42) = 16.048, p = 0.0002), and sex (F (1,42) = 8.293, p = 0.006). 
Significant effect of pellet x sex (F (1,42) = 17.1025, p = 0.019), time x pellet (F (6,252) = 
10.38, p < 0.0001) and time x genotype (F (6,252) = 2.69, p = 0.0014) were also 
observed. Overall, PDYN KO animals had a significantly lower motivation for 
obtaining palatable food than the WT controls, and highly palatable chocolate-
flavored pellets were preferred over normal food pellets. Over the course of time, 
WT female mice demonstrated a higher preference than PDYN KO female mice for 
chocolate-flavored pellets (Fig. 9E & F). Subsequently, under the FR5 schedule of 
reinforcement, significant effects of pellet (F (1,43) =17.54, p = 0.0001), genotype (F 
(1,43) = 6.835, p = 0.012) and sex (F (1,43) = 20.747, p < 0.0001) were observed (Fig. 9G 
& H). Similar to outcomes from the FR3 schedule, a highly significant preference for 
palatable chocolate-flavored pellets was revealed. WT mice activated the sensor 
significantly more compared to PDYN KO mice. This was observed particularly in 
female mice over the course of time (F (6,258) = 3.021, p = 0.0071).  
 Under the progressive ratio (PR) schedule, significant sex effect (p = 0.0058) 
was observed, however no significant genotype effect or interaction was seen. The 
breakpoint (BP) responding in female PDYN KO mice for chocolate-flavored pellets 
was significantly higher than normal pellets (p= 0.048) (Fig. 10A). In male mice, BP 
responding was similar in all groups (Fig. 10B). Furthermore, PDYN KO females 
displayed a significantly higher motivation compared to the male littermates for the 
palatable chocolate-flavored pellets (p = 0.005) (Fig. 10C).  
 The time to reach the criteria for the change of the operant conditioning 
schedule to the successive schedule is represented in table 8. It was observed during 
the experiment that male and female mice from the same group required similar 
number of days to acquire the task of operant conditioning. Hence the data from 
both the sexes was pooled together. Under the FR1 food deprivation schedule, the 
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mice reached the criteria in between 8 to 10 days for acquisition of the operant 
nose-poke task. There was no significant difference observed between the groups, 
during the acquisition phase. Next, in the FR1 schedule with AL access to food, mice 
required longer to achieve the criteria i.e. 10 to 16 days, particularly PDYN KO mice 
responding for palatable chocolate pellets. Under the AL access schedule, mice 
responded with their motivation (hedonic feeding) rather than hunger (homeostatic 
feeding). Therefore, the time required to achieve the stable responding for was 
longer than in the FR1 deprivation schedule. Consecutively, in the FR3 and FR5 
schedules, mice reached the criteria in the duration of a week, and between 7 to 8 
days, respectively.  
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Fig. 9. Operant motivational responding in PDYN KO and WT mice  
Panel A and B represent data from the average nose-poke responses in female and male 
mice under FR1 food deprivation schedule, panel C and D represent operant responses 
under FR1 AL schedule, panel E and F represents responses under FR3 schedule and 
panel G and H represents responses from the FR5 schedule of reinforcement. Females:  A, 
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C, E, male: B, D, F, n = 7- 8/group. *= pellet effect, # = genotype effect, */# p= 0.05, **/## p 
< 0.005, ***p < 0.0001, ****p<<0.0001. 
 
Fig. 10. Breakpoint under PR schedule in PDYN KO and WT mice 
 In PDYN KO groups, female mice had a significantly higher number of BP responding for 
palatable chocolate-flavored pellets compared to normal pellets (A), whereas, male mice 
had similar BP responding in all groups (B). Between sexes comparisons showed that PDYN 
KO females had significantly higher breakpoint than PDYN KO males for obtaining palatable 
chocolate-flavored pellets (C). PR = progressive ratio, BP = breakpoint, PDYN KO = 
prodynorphin knockout, WT = wild type, choc =chocolate-flavored pellets, n=5-8/group, *p 
< 0.05, **p < 0.005. 
 
 
Table 8. Time to reach criteria for operant schedules in PDYN KO and WT mice 
Operant schedules Time to reach criteria (days) 
Genotype PDYN KO  WT PDYN KO WT 
pellet type normal normal choc choc 
FR1 food deprivation 8 8 10 10 
FR1 AL 10 10 16 11 
FR3 7 7 7 7 
FR5 7 7 8 7 
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3.1.2 Operant motivational responding in PENK KO and PENK 
floxed mice  
 PENK KO and PENK floxed (control) mice were tested for their motivational 
responses in an operant conditioning paradigm. Under the FR1 schedule of 
conditioning a significant effect of pellet preference (F (10,41) = 2.68, p = 0.012), but 
no genotype effect was observed. Sex-separated analysis showed a significant effect 
of pellet preference (F (10,10) = 3.217, p = 0.039) in female and (F (10,22) = 2.371, p = 
0.043) in males, respectively (Fig. 11A & B). Both, PENK KO and PENK floxed mice, 
demonstrated a higher motivation to obtain highly palatable chocolate-flavored 
pellets over normal pellets. 
  Under the FR1 AL schedule of reinforcement, a significant effect of pellet 
preference (F (8,43) = 4.011, p = 0.0012) and pellet x genotype x sex (F (8,43) = 4.684, 
p=0.00035) interaction were observed. In female mice, a significant preference for 
pellet (F (8,12)= 2.849, p = 0.049) was observed, where female mice of both genotypes 
preferred palatable chocolate-flavored pellets as compared to normal pellets. A 
significant genotype x pellet interaction was observed in females (F (8,12) = 6.375, 
p=0.0023) as well as males (F (8,24) = 5.71, p = 0.0004) respectively (Fig. 11C & D). 
Overall, PENK KO mice preferred chocolate pellets than normal pellets. 
 Next, under the FR3 schedule, significant effect of pellet (F (6,45) = 7.519, p = 
0.00001), and strain x sex x pellet (F (6,45) = 2.332, p = 0.047) interaction were 
observed. Overall, significant effect of pellet was observed in female mice (F (6,14) = 
3.678, p = 0.020), and in male mice (F (6,26) = 4.85, p = 0.009), respectively (Fig. 11E 
& F). Both the sexes preferred palatable chocolate flavored-pellets to normal pellets, 
irrespective of their genotype. 
Successively, under the FR5 schedule, significant effect of pellet (F (5,46) = 
4.695, p = 0.0015), but no genotype or sex effect was observed. In sex-separated 
analysis, there was a significant pellet preference in females (F (5,12) = 2.495, p = 
0.0077) and in males (F (5,27) = 4.041, p = 0.007), respectively (Fig. 11G &H). PENK 
KO and PENK floxed mice preferred palatable chocolate-flavored pellets to normal 
pellets. 
Data from the progressive ratio schedule revealed a significant pellet effect (p 
= 0.00003) with a preference for the chocolate-flavored pellets over normal pellets 
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in all mice. Significant pellet preference was observed in female mice (p = 0.00018) 
and male mice (p = 0.0057), respectively (Fig. 12A & B). PENK KO and PENK floxed 
mice significantly showed higher motivational responding to obtain palatable 
chocolate-flavored pellets compared to the groups responding for normal pellets. 
There was no significant effect of genotype or sex observed.  
The time to reach criteria for FR schedules of reinforcement is represented 
for female and male mice, respectively (table 9). All the groups under the FR1 
schedule of deprivation required similar number of days, irrespective of the 
genotype or pellet. Female mice responding for chocolate-flavored pellets (10 days) 
achieved the acquisition task faster than females responding for normal pellets (12 
days). In case of males, PENK KO mice responding for chocolate-flavored groups 
required longer (13 days) for acquisition of the schedule compared to the other 
groups. Consecutively, under the FR5 schedule, PENK KO female and male mice 
responding for chocolate-flavored pellets required more number of days (10 days 
and 7 days, respectively) to achieve the criteria compared to other groups.  
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Fig. 11. Motivational responses under fixed ratio schedules in PENK KO and WT 
mice. Panel A and B represent data from the average nose-poke responses in female and 
male mice under FR1 food deprivation schedule, panel C and D represent operant 
responses under FR1 AL schedule, panel E and F represents responses under FR3 
schedule and panel G and H represents responses from the FR5 schedule of reinforcement. 
females:  A, C, E, G; male: B, D, F, H; n = 5-10/group, *p < 0.05, **p < 0.001. 
FR1 food deprivation 
0 1 2 3 4 5 6 7 8 9 10
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
*
*
FR1 AL
0 1 2 3 4 5 6 7 8
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
*
FR1 food deprivation 
0 1 2 3 4 5 6 7 8 9 10
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
*
FR5 AL
0 1 2 3 4 5
0
20
40
60
80
100
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
**
**
FR3 AL
0 1 2 3 4 5 6
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
*
FR1 AL
0 1 2 3 4 5 6 7 8
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
PENK floxed normal
PENK floxed choc
PENK KO normal
PENK KO choc
FR3 AL
0 1 2 3 4 5 6
0
20
40
60
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
**
FR5 AL
0 1 2 3 4 5
0
20
40
60
80
100
days
a
v
e
ra
g
e
 n
o
s
e
 p
o
k
e
s
**
**
Females Males
A B
C D
E F
HG
52 
 
 
 
 
Fig. 12.  Breakpoint under progressive ratio schedule in PDYN KO and WT mice 
Under the PR, the BP responding was significantly higher for chocolate-flavored pellets than 
normal pellets in PENK KO and PENK floxed females (A) and males (B), respectively. Time 
required to reach criteria for the different schedules in operant conditioning schedules were 
similar in all groups in female mice (C) as well as male mice (D). PR = progressive ratio, BP = 
breakpoint, PENK KO = proenkephalin knockout, FR = fixed ratio, choc = chocolate-flavored 
pellets, n=5-8/group, *p < 0.05. 
 
Table 9. Time to reach criteria in PENK KO and floxed mice. 
Operant 
schedules 
gender PENK KO  PENK floxed PENK KO PENK floxed 
 normal normal choc Choc 
FR1 food 
deprivation 
females 12 12 10 10 
males 10 11 10 13 
FR1 AL 
females 9 8 12 9 
males 8 9 11 11 
FR3 
females 6 8 7 9 
males 6 5 6 9 
FR5 
females 8 5 5 10 
males 6 5 5 7 
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3.2 Effects of diet, feeding, and metabolism 
 The effects of prolonged voluntary consumption of high-fat diet compared 
to normal diet in PDYN KO and WT mice, on the development of body weight 
regulation and metabolic changes was investigated. Furthermore, the groups were 
subjected to two different feeding regimens and assessed for the impact of time-
restricted feeding compared to ad libitum access in mice. Therefore, the results 
obtained are demonstrated in comparison of three factors i.e. genotype, diet and 
feeding regimen in both sexes.  
3.2.1 Effects of normal diet on PDYN KO and WT mice 
 First, the change in the body weight of PDYN KO and WT mice maintained 
on a normal diet, with ad libitum or intermittent access to food was determined. 
Analysis of the accumulated data (AUC) by 2-way ANOVA revealed main effects for 
the feeding schedule (F (1, 29) = 12.83, p = 0.0012) and genotype (F (1, 29) = 7.882, p = 
0.0088), but no interaction (F (1, 29) = 1,859, p = 0.1833) in females. In males, only a 
feeding effect (F (1, 28) = 7.219, p = 0.0120), but no effect of genotype and no 
interaction was observed. Post hoc analysis revealed a significantly higher body 
weight in the AL feeding groups as compared to TR feeding in WT animals. This 
was observed in both sexes (Fig. 13A, B). However, this effect was absent in PDYN 
KO mice. Furthermore, PDYN KO females on a TR schedule had a generally higher 
body weight than WT females (Fig. 13A).   
 Analysis of blood glucose levels showed a significant effect of feeding (F (1, 
30) = 5.582, p = 0.0248) in females, but no genotype effect and no interaction. Post 
hoc analysis revealed that blood glucose levels were significantly higher in PDYN 
KO females of the AL group, when compared to WT controls (Fig. 13C). In case of 
males, there were no significant differences (Fig. 13D).  
 As shown in Fig. 13 E & F, mice on AL feeding consumed a similar amount of 
food as TR feeding groups, although the variance was higher in the AL feeding 
groups. 
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Fig. 13. Effects of normal diet in PDYN KO and WT mice 
 The PDYN KO and WT animals maintained on a 12-week of normal diet during AL or TR 
feeding schedules are depicted in Fig.13.  A-F.  Line diagrams show the mean values of 
individual measurements, whereas bar graphs represent the cumulative (AUC) data. 
Scatter plot represents the food intake every week. (Panel A, C, E: female mice, Panel B, D, 
F: male mice, n = 7-12/group). * p < 0.05, ** p < 0.01, **** p < 0.0001. TR = time restricted 
feeding, AL = ad libitum feeding, WT = wild type mice, KO = PDYN KO /prodynorphin 
knockout mice. 
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3.2.2 Effects of high-fat diet on PDYN KO and WT mice 
 Analysis of body weight of WT and PDYN KO animals maintained on a high-
fat diet showed a main effect of genotype (F (1, 30) = 186.9, p < 0,0001), feeding 
schedule (F (1, 30) = 11.66, p = 0.0019) and an interaction effect (F (1, 30) = 4.647, p = 
0.0392) in female mice. Similarly, in male mice, a main effect was observed in 
genotype (F (1, 26) = 36.55, p < 0.0001) and feeding (F (1, 26) = 18.65, p = 0.0002), but 
no interaction (F (1, 26) = 0.7026, p = 0.4095). Post hoc analysis revealed a 
significantly higher body weight in the AL feeding groups as compared to TR 
feeding in WT animals. This was observed in both sexes (Fig. 14A, B). Furthermore, 
PDYN KO females on a TR schedule displayed higher body weights than WT 
females (Fig. 14A), whereas, PDYN KO males on an AL schedule had higher body 
weights as compared to WT male mice (Fig. 14B). 
 Blood glucose analysis revealed a main effect of genotype in females (F(1, 30) 
= 73.48, p < 0.0001) and in males (F(1, 26) = 18.85, p = 0.0002), as well as an effect of 
feeding schedule in females (F(1, 30) = 7.778, p = 0.0091) and in males (F(1, 26) = 
4.915, p = 0.0356), respectively. However, no interaction was observed in both 
sexes. A post hoc test revealed generally higher blood glucose levels in the AL 
compared to the TR schedule in WT animals (Fig. 14C, D). PDYN KO females on the 
AL schedule showed higher blood glucose levels than WT females (Fig. 14C), 
whereas in males, this effect was absent (Fig. 14D). Additionally, PDYN KO females 
on a TR schedule showed higher blood glucose levels compared to WT (Fig. 14C). 
 Food consumption was initially higher in the AL feeding groups (Fig. 14E 
and F), but eventually decreased to the same level as the TR feeding groups.  
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Fig. 14. Effects of HFD in PDYN KO and WT mice  
The PDYN KO and WT animals maintained on 12-weeks of high-fat diet during AL or TR 
feeding schedules are depicted in Fig. 14. A-F. Line diagrams show the mean values of 
individual measurements, whereas bar graphs represent the cumulative (AUC) data. 
Scatter plot represents the food intake for every week. Panel A, C, E: females, panel B, D, F: 
males, n = 7-12/group. * p < 0.05, ** p < 0.01, **** p < 0.0001. TR = time restricted feeding, 
AL = ad libitum feeding, WT = wild type mice, KO = PDYN KO/prodynorphin knockout 
mice. 
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3.3 Genotyping of PDYN KO mice  
 To assess the genotype of the mice, DNA analysis was performed using tail 
biopsies. After isolation of the DNA and polymerase chain reaction (PCR), was 
visualized using agarose gel electrophoresis. Bands of sizes 290 bp for WT animals 
and 500 bp for PDYN KO were produced (Fig. 15). 
 
 
 
 
 
 
 
 
 
 
Fig. 15. Genotyping of the PDYN KO and WT animals by PCR analysis  
Band size 290 bp depicted the WT allele and 500 bp depicted the PDYN KO allele.  
 
 
 
 
 
 
 
 
58 
 
 
3.4 Molecular analysis of hypothalamic peptides 
 Changes in the expression levels of hypothalamic NPY and orexin-A 
peptides in PDYN KO and WT mice were investigated by immunohistochemistry. 
The hypothalamic peptides levels of NPY were monitored in the ARC region 
whereas neuropeptide orexin-A levels were monitored in the LH region of the 
brain, respectively. The outcomes from the molecular analysis reflect the changes 
in the expression levels occurring after a high-fat diet or normal diet consumption. 
3.4.1 Neuropeptide-Y 
 Analysis of neuropeptide-Y (NPY) peptide signal intensity in females 
maintained on a normal diet revealed main effects for genotype (F (1, 8) = 26.20, p = 
0.0009) and feeding (F (1, 8) = 11.54, p = 0.0094), but no interaction. In males, the 
only main effect was observed for genotype (F (1, 8) = 6.359, p = 0.0357). In WT and 
PDYN KO animals on HFD, a main effect for genotype (F (1, 7) = 21.19, p = 0.0025) 
was seen in females, whereas in males, significant effects of genotype (F (1, 8) = 204, 
p < 0.0001) and feeding (F (1, 8) = 56.97, p < 0.0001) were calculated. No significant 
interaction was observed in both sexes. 
 Post hoc analysis showed that PDYN KO females maintained on ND had 
generally lower NPY expression levels in the ad libitum feeding groups as 
compared to time-restricted feeding (Fig. 16A). This effect was absent in males 
(Fig. 16B). Similarly, PDYN KO females on HFD showed lower NPY expression after 
AL feeding as compared to the TR feeding schedule (Fig. 16C). This effect was also 
observed in HFD-fed males, irrespective of the genotype (Fig. 16D). Additionally, 
PDYN KO males showed lesser NPY signal intensity as compared to WT males, in 
TR feeding as well as AL feeding schedule (Fig. 16D).  
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3.4.2 Orexin-A 
 Analysis of the hypothalamic peptide orexin-A in the lateral hypothalamus 
of female mice maintained on a ND showed main effects for genotype (F (1, 28) = 
23.40, p < 0.0001), feeding (F(1, 28) = 69.62, p < 0.0001) and interaction (F(1, 28) = 
68.83, p < 0.0001). In males, only an interaction effect (F (1, 22) = 7.292, p = 0.0131), 
but no genotype or feeding effect, was observed. In WT and PDYN KO mice 
maintained on a HFD, a significant effect of feeding (F (1, 27) = 25.23, P < 0.0001) 
was observed in females. In males, in addition to a main feeding effect (F (1, 22) = 
1.640, p = 0.2136), there was a genotype (F (1, 22) = 0.003081, p = 0.9562) and 
interaction effect (F (1, 22) = 7.292, p = 0.0131). Post hoc test of mice maintained on 
a normal diet revealed that WT females had generally higher orexin-A expression 
levels in ad libitum feeding group as compared to KO females (Fig. 17A). 
Additionally, AL-fed WT females had a higher signal density as compared to TR-fed 
females. In the TR feeding schedule, ND-fed male PDYN KO mice showed higher 
levels of orexin-A as compared to WT males (Fig. 17B). PDYN KO animals on HFD 
on AL feeding regimen generally showed lower orexin-A expression compared to 
WT mice. This effect was seen in both sexes (Fig. 17C, D). Furthermore, in PDYN KO 
males on AL feeding schedule showed lower signal density levels of orexin-A 
peptide as compared to the TR feeding group (Fig. 17D).  
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Fig. 16. Signal intensity of hypothalamic peptide NPY was analyzed in females and males 
maintained on a normal diet (A, B) and females and males on a high-fat diet (C, D), 
respectively. n= 3-5/ group. Females: A, C; Males B, D. WT = wild-type, KO = PDYN KO / 
prodynorphin knockout, TR = time restricted, AL = ad libitum, * p < 0.05, ** p < 0.01, **** p < 
0.0001.  
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Fig. 17. Integrated signal density of hypothalamic peptide orexin-A analyzed in females 
and males maintained on normal diet (A, B) and on a high-fat diet (C, D), respectively. n= 3-5/ 
group. Females: A, C; Males B, D. WT = wild type, KO = PDYN KO / prodynorphin knockout, TR 
= time restricted, AL = ad libitum, * p < 0.05, ** p < 0.01, **** p < 0.0001. 
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4 Discussion 
 In the present study the contribution of the two major classes of 
endogenous opioids, namely enkephalin and dynorphin in the modulation of 
hedonic control of feeding behavior was investigated. This behavior was assessed 
using palatable food pellets and standard normal food pellets in an operant 
conditioning task. Therefore, at first, the learning and motivation aspects of 
palatable reward-induced feeding behavior in dynorphin deficient and enkephalin 
deficient mice will be discussed. Another aim of the study focused on the 
modulation of feeding behavior and metabolism, where dynorphin deficient mice 
were exposed to prolonged voluntary high-fat diet consumption. The results 
demonstrating the impact of feeding behavior and diet regimen will be discussed. 
Lastly, the outcomes from the molecular changes of hypothalamic peptide 
expression following the different diet and feeding regimen, will be discussed in 
the later part of this section.  
4.1 Learning ability in an operant conditioning task  
 The present study demonstrates the role of endogenous opioids dynorphin 
and enkephalin in learning and motivation of palatable food rewards in an operant 
conditioning paradigm. The use of knockout mouse models in this study facilitates 
to explore the contribution of individual opioid ligand in natural reward-related 
reinforcement behaviors. Under the operant training schedule of FR1 food 
deprivation (acquisition phase) all groups of mice (PDYN KO, PENK KO, WT and 
PENK floxed), learnt the paradigm equally well, indicating intact learning abilities. 
The results were similar to a previous study showing intact learning abilities of 
dynorphin deficient mice, when trained under operant bar pressing responses for 
sucrose reinforcers (Hayward et al., 2006). Dynorphin has been suggested to play a 
modulatory role in cognitive acquisition and appear to enhance memory retention 
in negative reinforcement tasks, whereas, inhibitory effects on memory and 
learning in tasks based on positive stimuli (Kuzmin, Madjid, Terenius, Ogren, & 
Bakalkin, 2006; Wall & Messier, 2000). PENK KO mice also displayed similar 
learning abilities as the PENK floxed controls, during the operant learning phase, 
suggesting intact learning ability. In line with the current results, earlier research 
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on enkephalin deficient mice also showed an intact learning ability during a 
ethanol-reinforced operant conditioning task (Hayward, Hansen, Pintar, & Low, 
2004). Therefore, it can be concluded that the deficiency of endogeonous peptide 
enkephalin or dynorphin doesn't affect the learning behavior in an operant 
conditioning experiment. 
 
4.2 Motivational responding to obtain highly palatable 
food rewards 
 
 An important focus of this study was to evaluate the motivational 
responding for natural rewards in endogenous opioid knockout mice of either 
dynorphin or enkephalin, based on their palatability preferences. Animals were 
food-deprived during the first training phase to facilitate learning of nose-poke 
responses. However, an ad libitum access to food was provided during the 
remaining schedules of the experiment, in order to return the animals to normal 
physiological situation. Absence of food deprivation during the acquisition phase 
could have possibly led to decreased probability of food seeking-behavior in mice. 
Animals from all four groups i.e. PDYN KO, PENK KO, WT and PENK floxed, 
respectively, exhibited a prominent preference for the palatable chocolate-flavored 
pellets over normal pellets under all FR schedules. As both the food rewards were 
isocaloric in nature, the reinforcing property of chocolate pellets was its flavor 
rather than its caloric content. Similarly, previous studies on rats have shown a 
strong preference for flavor-based reinforcers such as saccharine or caffeine over 
unflavored reinforcers (Fedorchak, Mesita, Plater, & Brougham, 2002; Lockie & 
Andrews, 2013). PDYN KO male and female mice under FR1 ad libitum access 
schedule, showed a steady tendency of decreased motivation for palatable 
chocolate-flavored reinforcers as compared to their WT controls, however a 
prominent difference in the genotype was observed only in later FR3 and FR5 
schedules. Furthermore, this phenotype was also present in PDYN KO mice 
responding for standard normal pellets. Surprisingly, under the progressive ratio 
schedule of reinforcement, the genotype difference in PDYN KO and WT mice was 
lost. The PDYN KO mice, particularly females, sustained the higher responding rate 
for palatable chocolate-flavored pellets over normal pellets. PDYN KO females also 
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displayed higher number breakpoint responding than the male counterparts, 
suggesting that female mice are more vulnerable to hedonic signaling mechanisms 
than male mice. Dynorphin has been known to decrease the rewarding properties 
of drugs by lowering dopamine levels in the NAc  (Di Chiara & Imperato, 1988; 
Rainer Spanagel, Herz, & Shippenberg, 1990). This suggests that knockout of 
dynorphin would result in increased DA levels and increased motivation for food 
rewards in PDYN KO compared to WT, as hypothesized in the present study. 
However, contrary to the proposed hypothesis, the results showed decreased 
motivation in PDYN KO mice during the operant nose-poke task for palatable food 
rewards. The plausible reason for the decreased motivation in the PDYN KO could 
be that the deletion of dynorphin resulted in a compensatory increase in the 
number of endogenous KOR. Hence, in the absence of dynorphin, endogenous 
peptides such as met-enkephalin or ß- endorphin activate the KOR, resulting in the 
decrease of dopamine levels in the rewarding circuit. This might have resulted in 
the decreased motivation in the knockout animals. Supporting the present results, 
an earlier study in PDYN KO mice also demonstrated a strong reduction in the 
preference for saccharin compared to control mice. On the contrary, PDYN KO 
male mice showed enhanced ethanol preference in a two-bottled paradigm test 
(Blednov, Walker, Martinez, & Harris, 2006; Rácz et al., 2012). Together these data 
suggest that dynorphin plays a critical role in the differential modulation in 
reward-related behavior, however, depending upon the type of reward. 
  Lastly, under the progressive ratio schedule, PDYN KO mice did not differ 
than their controls in their motivational responses for obtaining the highly 
palatable food rewards. Therefore a genotype effect was missing. A prominent sex 
effect was observed under the progressive ratio schedule, where the PDYN KO 
females had higher number of operant responses compared to their male 
counterparts. Studies on operant-self administration of ethanol consumption also 
show difference in the responses in males and females in C57Bl/6 mice (Hayward 
et al., 2004; Middaugh & Kelley, 1999). Therefore, we can conclude that 
endogenous dynorphin is involved, but is not critically essential in the modulation 
of hedonic control of feeding behavior. 
 Assessment of the PENK KO mice in the operant conditioning paradigm, 
showed a considerable increase in the motivation to obtain palatable food rewards 
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compared to the PENK floxed control mice. A tendency of increased motivational 
behavior responses was noted, especially in female PENK KO mice, during the later 
FR schedules i.e. FR3 and FR5, respectively.  PENK floxed mice used in the study 
are known to have reduced levels of PENK mRNA compared to WT littermates 
(Britta Schürmann PhD thesis). Therefore, this could be one of the possible 
explanations for the absence of a genotype effect in the operant assessed 
modulation of the hedonic control of palatable food rewards. Furthermore, under 
progressive ratio schedule, the tendency of genotype difference that was observed 
during the fixed ratio schedules disappeared. Both, PENK KO male and female mice 
showed similar motivational responses for the highly palatable food rewards. The 
results from the PENK KO experiment as well contradicted the proposed 
hypothesis of the study. 
 These outcomes from the PDYN KO and PENK KO mice subjected to operant 
conditioning confirm the paradoxical finding to the proposed hypothesis. Both, 
PDYN KO and PENK KO mice failed to increase and decrease the motivation for 
palatable reward intake, respectively as compared to their controls. Furthermore, 
control animals, WT and PENK floxed mice showed a similar phenotypic behavior 
in the preference for palatable food rewards as the opioid peptide deficient mouse 
models. While the current data does not necessarily contradict the extensive 
pharmacological research findings suggesting opioids modulate the hedonic 
behavior, they do support a conclusion that neither of these peptides is essential in 
the operant self-administration behavior of palatable food intake. A possible 
explanation for the lack of any dramatic effect might be that other non-opioid 
pathways have compensated for the lack of enkephalin and dynorphin, resulting in 
the unpredictable phenotype.  
 In summary, the results present here support the hypothesis that the 
endogenous opioids can modulate palatable food intake, however, are not 
absolutely necessary for the hedonic aspect of feeding behavior. In line with the 
current results, opioid peptide knockout studies have previously showed that 
enkephalin and dynorphin modulate sucrose preference but are not necessary to 
support sucrose consumption (Hayward et al., 2006), therefore suggesting that 
these endogenous opioids may contribute to food and drug reinforcement via 
different neuronal pathways. 
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4.3 Effects of diet in feeding regimen in PDYN KO mice 
 In second part of this study based on metabolic changes induced by feeding 
behavior, PDYN KO and WT control animals were exposed to HFD or ND, under 
two different feeding regimens, TR or AL. AL feeding resulted in a more 
pronounced increase in body weight than TR feeding, although animals on AL 
consumed less food. The difference in body weight was particularly prominent in 
animals that were maintained on a HFD. PDYN KO mice were significantly heavier 
that wild type controls. This resulted in a weight pattern ranging from low to high 
in the following order WT TR, KO TR, WT AL and KO AL, respectively. This pattern 
was inversely correlated to the level of hypothalamic NPY expression. Differences 
between the sexes were observed.  
 The body weight data revealed that the constitutive deletion of dynorphin 
has a prominent impact on the body weight when maintained on a HFD. The ability 
of HFD formulation can increase body weight and disrupt cognition is linked to 
brain inflammation(Bruce-Keller et al., 2011). The exact mechanism how obesity 
detrimentally affects health is still unclear, and deregulation in metabolism is one 
of the key physiological factors of obesity (Pistell et al., 2010). The current results 
contradict the findings of a previous study, which found neither an effect of diet 
composition nor the dynorphin deletion on body weight (Sainsbury et al., 2010). 
These discrepancies may be due to the differences in HFD composition (46% fat, 
4.72 kcal/g versus 59% fat, 5.49 kcal/g) and the age of animals (7 weeks versus 12 
weeks). The body weight gain of the mice were in good agreement with other 
studies, where animals were exposed to similar diets and feeding conditions 
(Hatori et al., 2012). In line with the current data from food intake, previous 
studies on mice maintained on a high fat-diet during TR feeding also showed that 
animals consumed the same amount of calories as AL-fed animals, protecting them 
from weight gain and obesity. It is important to note that feeding episodes rather 
than the size of the meal, or total energy intake contributes to weight gain and 
development of obesity (Chaix, Zarrinpar, Miu, & Panda, 2014; Hatori et al., 2012; 
Murphy & Mercer, 2014). In agreement with this theory, the results showed that 
mice maintained on TR feeding regimen displayed lower body weights as 
compared to the AL feeding group. Furthermore, this effect was observed in all 
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animals irrespective of the type of diet consumed. However, in case of PDYN KO 
animals on HFD, the TR feeding groups had significantly higher body weights 
compared to WT controls. This implies that the loss of dynorphin contributes to a 
deregulation in metabolism inducing disturbed weight gain. Therefore, dynorphin 
peptide is a crucial factor involved in the regulation of the body weight of animals, 
when subjected to similar feeding conditions with a normal as well as with a high 
caloric diet.  
 Overweight human individuals restricted to eat only within a self-selected 
10–11 hour period on every other day showed outcomes where participants lost 
4% of body weight in 16 weeks and retained this weight loss for up to 1 year (Gill 
& Panda, 2015). During 6-month intermittent feeding, overweight human 
participants demonstrated effects such as lost abdominal fat, improved insulin 
sensitivity, as well as reduced blood pressure (Harvie et al., 2011). Interestingly, in 
normal weight men and women, three weeks of alternate day fasting also resulted 
in are similar to outcomes as animal studies showing that intermittent feeding can 
improve glucose metabolism even with little or no weight change (Anson et al., 
2003; Halberg et al., 2005). Therefore, time-restricted feeding seems to be a 
promising strategy in regulation of body weight and metabolism.  
  As the time of accessibility of food has a direct effect on body weight 
regulation, in the present study, this effect was seen to be independent on the type 
of diet consumed. Nocturnal rodents, such as mice and rats feed primarily during 
the dark hours and characteristically eat their largest meal shortly after the dark 
phase (lights off) initiates (Erickson, Clegg, & Palmiter, 1996; Green, Wilkinson, & 
Woods, 1992) To distinguish between consumption and response to a palatable 
stimulus, mice are usually provided with limited access to a highly palatable 
stimulus at a time different than their normal consumption period – e.g., during 
their active phase (lights on). This approach has been used for comparison of 
palatable responses in wild type and mutant mice (Blednov et al., 2006; Sindelar, 
Palmiter, Woods, & Schwartz, 2005).  
The effect of HFD consumption on the levels of blood glucose in PDYN KO female 
mice showed significant elevation as compared to the WT controls after 12 weeks, 
whereas in males similar levels were found in all feeding groups. In general, we 
also observed significantly higher body weights in PDYN KO male mice compared 
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to female mice, in the HFD feeding regimen. Furthermore, studies on sex-specific 
effects in body weight regulation have reported that HFD-fed males were more 
susceptible to weight gain compared to females, with similar energy intake. These 
alterations in body weight gain could either be a cause of a reduced metabolism or 
anti-obese effects of female estrogen that is mediated through the estrogen 
receptor α (Gao et al., 2007; Hwang et al., 2010; Winzell & Ahre, 2004).  
 It was observed that the feeding regimen or the timing of meal consumption 
had a crucial impact on the average food intake in mice. In general, animals fed on 
a TR feeding regimen devoured similar amount of food as mice on AL access. As 
this observation was made in all mice irrespective of the genotype, we can say that 
the constitutive absence of dynorphin does not play a role in the alteration of 
feeding behavior during different time schedules. The possible explanation for the 
higher food intake in TR groups is the binge-eating effect, which is an addiction-
like phenomenon characterized by excessive food consumption within discrete 
periods of time (Avena, Rada, & Hoebel, 2008; Blasio, Angelo, Steardo, Luca, 
Sabino, Valentina, and Cottone, 2012; Corwin, 2008). The motivation to obtain 
highly-palatable food increases during dietary restriction (Rossetti, Spena, Halfon, 
& Boutrel, 2014). Similar observations have been made in rodent models where 
shifting the normal feeding time de-synchronizes circadian rhythms and results in 
metabolic disorders and weight gain (Arble, Ramsey, & Ph, 2011). Human studies 
suggest that meal timings influence energy homeostasis and circadian-driven 
behavior (Murphy & Mercer, 2014). To conclude, lack of dynorphin causes a 
dysregulation of body weight and food intake in animals when maintained on a 
high-fat diet. These outcomes suggest that dynorphin modulates metabolic 
changes associated with diet composition and feeding regimen. 
 
4.4 Hypothalamic peptides in feeding behavior 
 The endogenous opioid system is involved in the homeostatic control 
mechanism by regulating the release of orexigenic hypothalamic peptides such as 
NPY and orexin-A. The activities of these hypothalamic peptides are dependent on 
opioid signaling, and it is known that dynorphin and NPY are important players in 
modulation of energy homeostasis and neuroendocrine regulation. Previous 
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research has shown that intracerebrovascular injections of NPY or dynorphin 
results in marked increase in food intake in fasted animals, demonstrating 
relatable role in central control of feeding behavior. Consequently, NPY produces 
significant effects on behavior and other functions, its most noticeable effect is the 
stimulation of feeding after central administration, and therefore, it is mainly 
involved in the regulation of feeding (Wisialowski et al., 2010).  
 The results from the present study showed that NPY expression levels in 
the ARC region of mice maintained on AL food were prominently lower than TR 
feeding. This outcome was observed in all PDYN KO animals, irrespective of the 
diet type. Hence, diet did not play a direct role in the hypothalamic peptide 
expression levels. Therefore, the data suggests that the feeding regimen, especially 
the time of food consumption, plays a crucial role in the regulation of NPY levels. 
The results are in line with a study that demonstrated the co-localization of NPY 
and dynorphin mRNA with a downregulation of NPY mRNA in PDYN KO mice (Lin 
et al., 2006). Neurons expressing the orexin-A peptide are well known to populate 
the lateral parts of the hypothalamus (Date et al., 1999; Yamamoto, Ueta, Date, 
Nakazato, & Hara, 1999),  Furthermore, orexigenic neurons in the lateral 
hypothalamus play a role in arousal, reward-seeking and feeding behavior (Harris 
et al., 2005). Therefore, orexin peptides are considered as appetite-stimulating 
neuropeptides that regulate body weight homeostasis (Sakurai, 2014). The results 
from immunostaining showed that orexin-A peptide levels in PDYN KO mice 
during the AL feeding regimen were significantly lower compared to the TR 
feeding group. These results are similar to the NPY outcome, indicating that both 
orexigenic peptides show upregulation in TR-fed mice. Therefore, the impact of TR 
feeding regimen is prominent in case of modulation of hypothalamic orexigenic 
peptides as well. 
 In summary, this work has revealed for the first time a significant role of 
endogenous dynorphin in modulation of metabolic changes occurring after a 
prolonged consumption of different diets, under different feeding considering both 
the male and female sexes of mice. Comparison of these several factors at once in 
PDYN KO and WT mice was crucial to elucidate and specifically identify the main 
components influencing the alteration of diet-induced metabolism. 
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5 Conclusion 
 The endogenous opioid system is known to be involved in the modulation of 
hedonic and homeostatic control of feeding behaviors. So far, several studies have 
elucidated the involvement of the opioid signaling in the brain reward circuitry in 
the context of natural reward and feeding behaviors. Most evidence implicating 
endogenous opioids is based on studies using pharmacological or genetic knockout 
of opioid receptors, which alters feeding behaviors. However, individual 
contribution of each opioid peptide in feeding behavior and metabolism is not 
entirely clear. With the use of genetically modified mouse models of endogenous 
peptides, the present study assessed the impact of palatable-reward induced 
feeding behavior as well as metabolic changes after exposure of the animals to 
different diet conditions. 
 This study aimed to distinguish the role of the two major classes of 
endogenous opioids, namely enkephalin and dynorphin, in the motivational aspect 
of feeding behavior. Prodynorphin knockout and proenkephalin knockout mice 
were presented with a highly palatable chocolate-flavored pellet or a normal pellet 
and tested in an operant-self administration paradigm. It was hypothesized that 
the knockout of dynorphin will increase the rewarding behavior in mice towards 
high-palatable food, whereas, knockout of enkephalin will decrease the rewarding 
behavior. The proenkephalin knockout and prodynorphin mice showed a higher 
preference for the palatable chocolate-flavored pellets compared to the normal 
food pellets. However, no significant genotype effect was absent under the 
progressive ratio schedule assessment. These findings suggest that the 
endogenous opioids enkephalin and dynorphin are involved in the modulation of 
the reward-induced motivation but play no essential role in the hedonic aspects of 
feeding behavior. 
 The present findings evidently support the assumption that a dysregulation 
in the endogenous opioid system causes modulation in the reward mechanism in 
mice. Deficiency of dynorphin seems to negatively affects the body weight and 
metabolism, after high caloric diet consumption. Prodynorphin deficient and wild 
type mice were maintained for twelve weeks on a high-fat diet or a normal chow 
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with either a time-restricted access or an ad libitum access to food. The results 
show that prodynorphin deficient mice gained significantly higher body weight 
compared to the wild-type controls, and this effect was prominently observed in 
male mice. Food intake in both genotypes was found to be similar. Furthermore, an 
immunohistochemical analysis of hypothalamic peptides involved in homeostatic 
feeding behavior, demonstrated that prodynorphin deficient animals displayed 
significantly reduced levels of  hypothalamic orexigenic peptides NPY and orexin-A 
under different feeding regimens. Furthermore, prodynorphin knockout mice 
maintained on an ad libitum high-fat diet feeding had lower levels of orexin-A 
expressions compared to wild-type controls. These results suggest that the 
modulation in hypothalamic peptide expression is an effect of the feeding regimen, 
than the effect of diet itself. 
  Taken together, the results from the study suggest that endogenous opioid 
peptide dynorphin not only contributes to the modulation motivated-feeding 
behavior but also is crucial in the homeostatic control of feeding behavior. 
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